ATM
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00213 | S228 | PSP | APBB1 FE65 RIR | LLFGMRNSAASDEDSSWATLsQGSPSYGSPEDTDSFWNPNA |
| O00255 | S394 | PSP | MEN1 SCG2 | NLLKEAASLLEAGEERPGEQsQGTQSQGSALQDPECFAHLL |
| O14757 | S317 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CHEK1 CHK1 | NLDFsPVNsAssEENVKYsssQPEPRTGLsLWDtsPsYIDK |
| O14757 | S345 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK1 CHK1 | LsLWDtsPsYIDKLVQGISFsQPTCPDHMLLNSQLLGTPGS |
| O15111 | S473 | PSP | CHUK IKKA TCF16 | LSLLRYNANLTKMKNTLISAsQQLKAKLEFFHKSIQLDLER |
| O15151 | S342 | SIGNOR | MDM4 MDMX | RCWALRKDWYSDCSKLtHsLstsDItAIPEKENEGNDVPDC |
| O15151 | S367 | SIGNOR | MDM4 MDMX | tAIPEKENEGNDVPDCRRtIsAPVVRPKDAYIKKENSKLFD |
| O15151 | S403 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | MDM4 MDMX | SKLFDPCNSVEFLDLAHSSEsQETISSMGEQLDNLSEQRTD |
| O15164 | S217 | PSP | TRIM24 RNF82 TIF1 TIF1A | TKDHTVRQKEEVsPEAVGVTsQRPVFCPFHKKEQLKLYCET |
| O15164 | S768 | PSP | TRIM24 RNF82 TIF1 TIF1A | SRPQNANYPRSILtsLLLNssQsstsEETVLRSDAPDSTGD |
| O15164 | S808 | PSP | TRIM24 RNF82 TIF1 TIF1A | DQPGLHQDNSsNGKsEWLDPsQKsPLHVGETRKEDDPNEDW |
| O15355 | S183 | SIGNOR|EPSD|PSP | PPM1G PPM1C | NCHKGPPHSKsGGGtGEEPGsQGLNGEAGPEDstREtPsQE |
| O15360 | S1449 | SIGNOR | FANCA FAA FACA FANCH | DPEVSAALQSRQQAAPDADLsQEPHLF______________ |
| O43504 | S26 | EPSD|PSP | LAMTOR5 HBXIP XIP | EQHLEDTMKNPSIVGVLCtDsQGLNLGCRGTLSDEHAGVIS |
| O43670 | S104 | PSP | ZNF207 BUGZ | GIPEKDMDERRRLLEQKTQEsQKKKQQDDSDEYDDDDSAAS |
| O43683 | S314 | SIGNOR|EPSD|PSP | BUB1 BUB1L | DELHKKLHQVVEtsHEDLPAsQERsEVNPARMGPSVGsQQE |
| O43684 | S135 | SIGNOR|PSP | BUB3 | SWDQTVKLWDPRtPCNAGTFsQPEKVytLSVSGDRLIVGTA |
| O43791 | S119 | PSP | SPOP | RAKFKFSILNAKGEETKAMEsQRAYRFVQGKDWGFKKFIRR |
| O60934 | S278 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NBN NBS NBS1 P95 | EEHNFFLAPGTCVVDTGITNsQTLIPDCQKKWIQSIMDMLQ |
| O60934 | S343 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NBN NBS NBS1 P95 | CDPQGHPSTGLKtttPGPsLsQGVsVDEKLMPSAPVNTTTY |
| O60934 | S397 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NBN NBS NBS1 P95 | LSERPKEIKVSKMEQKFRMLsQDAPTVKESCKtssNNNSMV |
| O60934 | S615 | SIGNOR|EPSD|PSP | NBN NBS NBS1 P95 | MDIETNDtFsDEAVPEssKIsQENEIGKKRELKEDSLWSAK |
| O75150 | S114 | SIGNOR|EPSD|PSP | RNF40 BRE1B KIAA0661 | VNRYWAQLDETVEALLRCHEsQGELSSAPEAPGTQEGPTCD |
| O75150 | S819 | EPSD|PSP | RNF40 BRE1B KIAA0661 | IHKLLREEKDELGEQVLGLKsQVDAQLLTVQKLEEKERALQ |
| O75150 | S853 | EPSD|PSP | RNF40 BRE1B KIAA0661 | EKERALQGSLGGVEKELTLRsQALELNKRKAVEAAQLAEDL |
| O75943 | S646 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RAD17 R24L | EESLGEPtQATVPETWSLPLsQNSASELPAsQPQPFSAQGD |
| O75943 | S656 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RAD17 R24L | TVPETWSLPLsQNSASELPAsQPQPFSAQGDMEENIIIEDy |
| O75943 | T633 | PSP | RAD17 R24L | SGDEAQLNGGHSAEESLGEPtQATVPETWSLPLsQNSASEL |
| O94874 | S462 | GPS6|SIGNOR|PSP | UFL1 KIAA0776 MAXER NLBP RCAD | EYKIKKVKKKGRKDDDsDDEsQSSHTGKKKPEISFMFQDEI |
| O94916 | S1197 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFAT5 KIAA0827 TONEBP | EQQAAFQQQAPISHIQTPMLsQEQAQPPQQGLFQPQVALGS |
| O94916 | S1247 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFAT5 KIAA0827 TONEBP | QQGTMFQSQHSIVAMQSNSPsQEQQQQQQQQQQQQQQQQQS |
| O94916 | S1367 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFAT5 KIAA0827 TONEBP | SQTPLFHSSPQIQLVQGSPSsQEQQVTLFLSPASMSALQTS |
| O95071 | S1532 | EPSD|PSP | UBR5 EDD EDD1 HYD KIAA0896 | ELFSVEPLPPRPSSDQSSSSsQSQSSYIIRNPQQRRIsQsQ |
| O95071 | S1679 | EPSD|PSP | UBR5 EDD EDD1 HYD KIAA0896 | AFFSEDDSQSNDSSDSDSSSsQSDDIEQETFMLDEPLERTt |
| O95071 | S174 | EPSD|PSP | UBR5 EDD EDD1 HYD KIAA0896 | SRRQTRVIRTGRDRGsGLLGsQPQPVIPASVIPEELIsQAQ |
| O95071 | S191 | EPSD|PSP | UBR5 EDD EDD1 HYD KIAA0896 | LLGsQPQPVIPASVIPEELIsQAQVVLQGKsRsVIIRELQR |
| O95071 | S2586 | EPSD|PSP | UBR5 EDD EDD1 HYD KIAA0896 | HDFAFFDPVMYESLRQLILAsQSSDADAVFSAMDLAFAIDL |
| O96017 | S19 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CHEK2 CDS1 CHK2 RAD53 | __MSRESDVEAQQSHGSSACsQPHGSVtQsQGSSsQsQGIS |
| O96017 | S28 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | EAQQSHGSSACsQPHGSVtQsQGSSsQsQGISSSSTSTMPN |
| O96017 | S33 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | HGSSACsQPHGSVtQsQGSSsQsQGISSSSTSTMPNSsQSS |
| O96017 | S35 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | SSACsQPHGSVtQsQGSSsQsQGISSSSTSTMPNSsQSSHS |
| O96017 | S50 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CHEK2 CDS1 CHK2 RAD53 | GSSsQsQGISSSSTSTMPNSsQSSHSSSGTLSsLETVStQE |
| O96017 | T26 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | DVEAQQSHGSSACsQPHGSVtQsQGSSsQsQGISSSSTSTM |
| O96017 | T68 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | NSsQSSHSSSGTLSsLETVStQELYsIPEDQEPEDQEPEEP |
| O96028 | S102 | EPSD|PSP | NSD2 KIAA1090 MMSET TRX5 WHSC1 | LTSRVFNGEPGAHDAKLRFEsQEMKGIGtPPNttPIKNGsP |
| P00519 | S446 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | ABL1 ABL JTK7 | GVLLWEIATYGMSPYPGIDLsQVYELLEKDYRMERPEGCPE |
| P04637 | S15 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S20 | SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | _MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQAM |
| P04637 | S33 | iPTMNet|PSP | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S37 | iPTMNet|PSP | TP53 P53 | EtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQWFtED |
| P04637 | S46 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04637 | S9 | SIGNOR|iPTMNet | TP53 P53 | ____________MEEPQsDPsVEPPLsQEtFsDLWKLLPEN |
| P07900 | T5 | EPSD|PSP | HSP90AA1 HSP90A HSPC1 HSPCA | ________________MPEEtQtQDQPMEEEEVETFAFQAE |
| P07900 | T7 | EPSD|PSP | HSP90AA1 HSP90A HSPC1 HSPCA | ______________MPEEtQtQDQPMEEEEVETFAFQAEIA |
| P08047 | S101 | GPS6|SIGNOR|EPSD|PSP | SP1 TSFP1 | SQGPSQSGGTGELDLTATQLsQGANGWQIISSSSGATPTSK |
| P08047 | S56 | EPSD|PSP | SP1 TSFP1 | sQARssstGsssstGGGGQEsQPsPLALLAATCSRIESPNE |
| P11166 | S490 | PSP | SLC2A1 GLUT1 | GGAsQsDKtPEELFHPLGADsQV__________________ |
| P12956 | S27 | SIGNOR|EPSD|PSP | XRCC6 G22P1 | YYKtEGDEEAEEEQEENLEAsGDyKYsGRDsLIFLVDASKA |
| P12956 | S33 | SIGNOR|EPSD|PSP | XRCC6 G22P1 | DEEAEEEQEENLEAsGDyKYsGRDsLIFLVDASKAMFEsQS |
| P14618 | T328 | PSP | PKM OIP3 PK2 PK3 PKM2 | LAQKMMIGRCNRAGKPVICAtQMLEsMIKKPRPTRAEGsDV |
| P15336 | S490 | GPS6|SIGNOR|EPSD|PSP | ATF2 CREB2 CREBP1 | EAVATSVLTQMADQSTEPALsQIVMAPSsQSQPSGS_____ |
| P15336 | S498 | GPS6|SIGNOR|EPSD|PSP | ATF2 CREB2 CREBP1 | TQMADQSTEPALsQIVMAPSsQSQPSGS_____________ |
| P15374 | S75 | SIGNOR|EPSD|PSP | UCHL3 | LFPITEKYEVFRTEEEEKIKsQGQDVTSSVYFMKQTISNAC |
| P15927 | S23 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | NsGFEsYGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARA |
| P15927 | S29 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | YGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARAQHIVPC |
| P15927 | T21 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | MWNsGFEsYGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRA |
| P16104 | S140 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | H2AX H2AFX | KtsAtVGPKAPSGGKKAtQAsQEy_________________ |
| P16220 | S107 | SIGNOR|PSP | CREB1 | QISTIAEsEDsQEsVDsVTDsQKRREILsRRPsYRKILNDL |
| P16220 | S119 | PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16220 | S97 | SIGNOR|PSP | CREB1 | VIQSPQVQTVQISTIAEsEDsQEsVDsVTDsQKRREILsRR |
| P20823 | S249 | SIGNOR|PSP | HNF1A TCF1 | RETLVEECNRAECIQRGVsPsQAQGLGSNLVTEVRVYNWFA |
| P22681 | S866 | PSP | CBL CBL2 RNF55 | PAASAATASPQLSSEIENLMsQGYSYQDIQKALVIAQNNIE |
| P22681 | T640 | PSP | CBL CBL2 RNF55 | LPFsLPSQMEPRPDVPRLGstFsLDtsMsMNssPLVGPECD |
| P23025 | S173 | SIGNOR|iPTMNet|EPSD|PSP | XPA XPAC | CDLEKREPPLKFIVKKNPHHsQWGDMKLYLKLQIVKRSLEV |
| P23025 | S196 | SIGNOR|iPTMNet|EPSD|PSP | XPA XPAC | GDMKLYLKLQIVKRSLEVWGsQEALEEAKEVRQENREKMKQ |
| P23919 | S88 | PSP | DTYMK CDC8 TMPK TYMK | VHLLFSANRWEQVPLIKEKLsQGVTLVVDRYAFSGVAFTGA |
| P25205 | S535 | GPS6|SIGNOR|EPSD|PSP | MCM3 | GDAMPLGSAVDILATDDPNFsQEDQQDTQIYEKHDNLLHGT |
| P27707 | S74 | SIGNOR|EPSD|PSP | DCK | PVARWCNVQstQDEFEELtMsQKNGGNVLQMMYEKPERWSF |
| P31749 | S473 | EPSD | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P35637 | S42 | EPSD|PSP | FUS TLS | GQGYsQQSsQPYGQQSYSGYsQSTDTSGYGQSsYSSYGQsQ |
| P37275 | S585 | PSP | ZEB1 AREB6 TCF8 | EAEKPEssVssAtGDGNLsPsQPPLKNLLSLLKAYYALNAQ |
| P38398 | S1189 | EPSD|PSP | BRCA1 RNF53 | DIKESsAVFSKsVQKGELsRsPsPFtHTHLAQGYRRGAKKL |
| P38398 | S1330 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | BRCA1 RNF53 | TNTQDPFLIGSSKQMRHQsEsQGVGLsDKELVsDDEERGTG |
| P38398 | S1387 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BRCA1 RNF53 | EAASGCESETSVSEDCSGLSsQSDILTtQQRDTMQHNLIKL |
| P38398 | S1423 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BRCA1 RNF53 | NLIKLQQEMAELEAVLEQHGsQPSNSYPSIISDSSALEDLR |
| P38398 | S1457 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BRCA1 RNF53 | SALEDLRNPEQSTSEKAVLtsQKssEYPIsQNPEGLsADKF |
| P38398 | S1466 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | BRCA1 RNF53 | EQSTSEKAVLtsQKssEYPIsQNPEGLsADKFEVsADssTs |
| P38398 | S1497 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BRCA1 RNF53 | FEVsADssTsKNKEPGVERssPSKCPsLDDRWYMHSCsGSL |
| P38398 | S1524 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BRCA1 RNF53 | LDDRWYMHSCsGSLQNRNyPsQEELIKVVDVEEQQLEEsGP |
| P38398 | S1542 | SIGNOR|EPSD|PSP | BRCA1 RNF53 | yPsQEELIKVVDVEEQQLEEsGPHDLtEtsyLPRQDLEGTP |
| P40692 | S406 | EPSD|PSP | MLH1 COCA2 | TDsREQKLDAFLQPLsKPLssQPQAIVTEDKTDISSGRARQ |
| P41236 | S44 | GPS6|SIGNOR|EPSD|PSP | PPP1R2 IPP2 | sMVAsAEQPRGNVDEELSKKsQKWDEMNILAtyHPADKDyG |
| P43243 | S208 | PSP | MATR3 KIAA0723 | sFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGE |
| P46379 | S218 | EPSD|PSP | BAG6 BAT3 G3 | QHSQPPPQPPAVtPEPVALSsQTSEPVESEAPPREPMEAEE |
| P46379 | S26 | EPSD|PSP | BAG6 BAT3 G3 | stSTAVEEPDSLEVLVKTLDsQTRTFIVGAQMNVKEFKEHI |
| P46527 | S140 | EPSD|PSP | CDKN1B KIP1 p27 | GAPANSEDTHLVDPKTDPsDsQTGLAEQCAGIRKRPAtDDS |
| P46937 | Y391 | PSP | YAP1 YAP65 | sQELRTMttNssDPFLNsGtyHsRDEstDsGLsMssysVPR |
| P49591 | S101 | PSP | SARS1 SARS SERS | PENVLSFDDLTADALANLKVsQIKKVRLLIDEAILKCDAER |
| P49591 | S241 | PSP | SARS1 SARS SERS | IPIYTPFFMRKEVMQEVAQLsQFDEELyKVIGKGSEKSDDN |
| P49917 | S199 | GPS6|ELM|iPTMNet|EPSD | LIG4 | SALEQKWLIRMIIKDLKLGVsQQTIFSVFHNDAAELHNVTT |
| P49959 | S264 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MRE11 HNGS1 MRE11A | GHEHECKIAPTKNEQQLFYIsQPGssVVtsLsPGEAVKKHV |
| P49959 | S676 | EPSD|PSP | MRE11 HNGS1 MRE11A | FPTTSKTDQRWSSTSSSKIMsQsQVsKGVDFEssEDDDDDP |
| P49959 | S678 | EPSD|PSP | MRE11 HNGS1 MRE11A | TTSKTDQRWSSTSSSKIMsQsQVsKGVDFEssEDDDDDPFM |
| P50542 | S141 | SIGNOR|EPSD|PSP | PEX5 PXR1 | EFLAAGDAVDVTQDYNETDWsQEFISEVTDPLSVSPARWAE |
| P51532 | S721 | EPSD|PSP | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | VDARHIIENAKQDVDDEyGVsQALARGLQSyyAVAHAVTER |
| P54132 | T122 | GPS6|EPSD|PSP | BLM RECQ2 RECQL3 | GGSKSLLPDFLQtPKEVVCTtQNtPtVKKSRDTALKKLEFs |
| P54132 | T99 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | BLM RECQ2 RECQL3 | NTTNQQRVKDFFKNAPAGQEtQRGGSKSLLPDFLQtPKEVV |
| P54274 | S219 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TERF1 PIN2 TRBF1 TRF TRF1 | RIFGDPNSHMPFKSKLLMIIsQKDTFHSFFQHFSYNHMMEK |
| P54274 | S367 | PSP | TERF1 PIN2 TRBF1 TRF TRF1 | STKKKKESRRAtESRIPVSKsQPVtPEKHRARKRQAWLWEE |
| P54646 | T172 | SIGNOR|PSP | PRKAA2 AMPK AMPK2 | NAKIADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| P55072 | S326 | EPSD|PSP | VCP HEL-220 HEL-S-70 | LDAIAPKREKTHGEVERRIVsQLLTLMDGLKQRAHVIVMAA |
| P60484 | S113 | EPSD|PSP | PTEN MMAC1 TEP1 | HNPPQLELIKPFCEDLDQWLsEDDNHVAAIHCKAGKGRTGV |
| P60484 | T398 | EPSD|PSP | PTEN MMAC1 TEP1 | RYsDttDsDPENEPFDEDQHtQItKV_______________ |
| P78527 | S2612 | EPSD|PSP | PRKDC HYRC HYRC1 | DSDWRFRSTVLtPMFVEtQAsQGtLQtRtQEGsLSARWPVA |
| P78527 | S3205 | PSP | PRKDC HYRC HYRC1 | NRCFFLSKIEEKLtPLPEDNsMNVDQDGDPsDRMEVQEQEE |
| P78527 | T2609 | SIGNOR|EPSD|PSP | PRKDC HYRC HYRC1 | YTIDSDWRFRSTVLtPMFVEtQAsQGtLQtRtQEGsLSARW |
| P78527 | T2638 | EPSD|PSP | PRKDC HYRC HYRC1 | tRtQEGsLSARWPVAGQIRAtQQQHDFtLtQtADGRssFDW |
| P78527 | T2647 | EPSD|PSP | PRKDC HYRC HYRC1 | ARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPL |
| Q00987 | S386 | SIGNOR|EPSD|PSP | MDM2 | IVNDSREsCVEENDDKITQAsQSQESEDysQPSTSsSIIyS |
| Q00987 | S395 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MDM2 | VEENDDKITQAsQSQESEDysQPSTSsSIIySsQEDVKEFE |
| Q00987 | S401 | iPTMNet | MDM2 | KITQAsQSQESEDysQPSTSsSIIySsQEDVKEFEREEtQD |
| Q00987 | S407 | PSP | MDM2 | QSQESEDysQPSTSsSIIySsQEDVKEFEREEtQDKEEsVE |
| Q00987 | S425 | PSP | MDM2 | ySsQEDVKEFEREEtQDKEEsVESsLPLNAIEPCVICQGRP |
| Q00987 | S429 | SIGNOR|EPSD|PSP | MDM2 | EDVKEFEREEtQDKEEsVESsLPLNAIEPCVICQGRPKNGC |
| Q00987 | T419 | PSP | MDM2 | TSsSIIySsQEDVKEFEREEtQDKEEsVESsLPLNAIEPCV |
| Q01094 | S31 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | E2F1 RBBP3 | PCAPALEALLGAGALRLLDSsQIVIISAAQDASAPPAPTGP |
| Q01844 | T79 | EPSD|PSP | EWSR1 EWS | ATYGQTAYATSYGQPPTGYttPtAPQAYSQPVQGYGTGAYD |
| Q02535 | S65 | EPSD|PSP | ID3 1R21 BHLHB25 HEIR1 | NHCySRLRELVPGVPRGTQLsQVEILQRVIDYILDLQVVLA |
| Q02880 | S1135 | SIGNOR | TOP2B | QEKAAEEDETQNQHDDSsSDsGTPSGPDFNYILNMSLWSLT |
| Q03111 | S394 | EPSD|PSP | MLLT1 ENL LTG19 YEATS1 | SSPSNSSSSSDSSSDSDFEPsQNHsQGPLRSMVEDLQsEEs |
| Q03111 | S398 | EPSD|PSP | MLLT1 ENL LTG19 YEATS1 | NSSSSSDSSSDSDFEPsQNHsQGPLRSMVEDLQsEEsDEDD |
| Q03112 | S1037 | SIGNOR | MECOM EVI1 MDS1 PRDM3 | DKEDAYFTEIRNFIGNSNHGsQsPRNVEERMNGSHFKDEKA |
| Q03112 | S1039 | SIGNOR | MECOM EVI1 MDS1 PRDM3 | EDAYFTEIRNFIGNSNHGsQsPRNVEERMNGSHFKDEKALV |
| Q07666 | S388 | PSP | KHDRBS1 SAM68 | EYGYDDTYAEQSYEGYEGYYsQsQGDSEYYDYGHGEVQDSY |
| Q07666 | S390 | PSP | KHDRBS1 SAM68 | GYDDTYAEQSYEGYEGYYsQsQGDSEYYDYGHGEVQDSYEA |
| Q07666 | T61 | PSP | KHDRBS1 SAM68 | PHRSRGGGGGSRGGARAsPAtQPPPLLPPSAtGPDATVGGP |
| Q09472 | S106 | SIGNOR|EPSD|PSP | EP300 P300 | RsGssPNLNMGVGGPGQVMAsQAQQSSPGLGLINSMVKSPM |
| Q12888 | S1219 | SIGNOR|EPSD|PSP | TP53BP1 | ERGsGEKPVsAPGDDtEsLHsQGEEEFDMPQPPHGHVLHRH |
| Q12888 | S1778 | EPSD|PSP | TP53BP1 | ssEEEEEFLEIPPFNKQYTEsQLRAGAGYILEDFNEAQCNT |
| Q12888 | S25 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53BP1 | GsQLDSDFSQQDTPCLIIEDsQPEsQVLEDDSGSHFSMLSR |
| Q12888 | S29 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53BP1 | DSDFSQQDTPCLIIEDsQPEsQVLEDDSGSHFSMLSRHLPN |
| Q12888 | S6 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | TP53BP1 | _______________MDPTGsQLDSDFSQQDTPCLIIEDsQ |
| Q12888 | S784 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | TP53BP1 | PsPRVDVsCEPLEGVEKCsDsQsWEDIAPEIEPCAENRLDt |
| Q12888 | S831 | SIGNOR | TP53BP1 | EYEGDLKsGtAEtEPVEQDssQPsLPLVRADDPLRLDQELQ |
| Q12888 | T302 | SIGNOR | TP53BP1 | QELMEsGLQIQKsPEPEVLstQEDLFDQsNKtVssDGCstP |
| Q13098 | S474 | EPSD|PSP | GPS1 COPS1 CSN1 | MLRAAVLRNQIHVKsPPREGsQGELtPANsQsRMstNM___ |
| Q13263 | S824 | GPS6|EPSD|PSP | TRIM28 KAP1 RNF96 TIF1B | KFSAVLVEPPPMsLPGAGLssQELsGGPGDGP_________ |
| Q13315 | S1893 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | ATM | CLRHFsQtsRsttPANLDsEsEHFFRCCLDKKSQRTMLAVV |
| Q13315 | S1981 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ATM | YADKKSMDDQEKRSLAFEEGsQSTtIssLSEKsKEETGISL |
| Q13315 | S1987 | iPTMNet | ATM | MDDQEKRSLAFEEGsQSTtIssLSEKsKEETGISLQDLLLE |
| Q13315 | S2996 | GPS6|SIGNOR|EPSD|PSP | ATM | DETELHPTLNADDQECKRNLsDIDQSFNKVAERVLMRLQEK |
| Q13315 | S367 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | ATM | ELMADICHQVFNEDTRSLEIsQSyTttQRESSDYSVPCKRK |
| Q13315 | S440 | SIGNOR|iPTMNet|EPSD|PSP | ATM | ISKYPASLPNCELSPLLMILsQLLPQQRHGERTPYVLRCLT |
| Q13315 | T1885 | GPS6|EPSD|PSP | ATM | HVQGFFTSCLRHFsQtsRsttPANLDsEsEHFFRCCLDKKS |
| Q13362 | S520 | SIGNOR|EPSD|PSP | PPP2R5C KIAA0044 | PQDPHTKKALEAHCRADELAsQDGR________________ |
| Q13535 | T1989 | GPS6 | ATR FRP1 | VHQALIVLQKGVELCFPENEtPPEGKNMLIHGRAMLLVGRF |
| Q13541 | S112 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13541 | S8 | GPS6|ELM|iPTMNet|EPSD | EIF4EBP1 | _____________MsGGssCsQtPSRAIPATRRVVLGDGVQ |
| Q13541 | S94 | EPSD|PSP | EIF4EBP1 | DLPtIPGVtsPssDEPPMEAsQsHLRNsPEDKRAGGEEsQF |
| Q13769 | S307 | PSP | THOC5 C22orf19 KIAA0983 | SVAIEGSVDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRP |
| Q13769 | S312 | PSP | THOC5 C22orf19 KIAA0983 | GSVDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQ |
| Q13769 | S314 | PSP | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q14161 | S384 | EPSD|PSP | GIT2 KIAA0148 | GsKDNVELILKTINNQHSVEsQDNDQPDyDsVAsDEDtDLE |
| Q14161 | T195 | EPSD|PSP | GIT2 KIAA0148 | SKAGQILQAELLAVYGADPGtQDSSGKTPVDYARQGGHHEL |
| Q14190 | S115 | PSP | SIM2 BHLHE15 | VASDGKIMYISETASVHLGLsQVELTGNSIYEYIHPSDHDE |
| Q14191 | S1141 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | WRN RECQ3 RECQL2 | GSNISKKsIMVQsPEKAySSsQPVISAQEQETQIVLYGKLV |
| Q14191 | S1292 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | WRN RECQ3 RECQL2 | PLKSIAESRILPLMTIGMHLsQAVKAGCPLDLERAGLTPEV |
| Q14247 | S113 | PSP | CTTN EMS1 | DRMDKsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVD |
| Q14457 | T57 | PSP | BECN1 GT197 | VTIQELTAPLLTTAQAKPGEtQEEEtNsGEEPFIETPRQDG |
| Q14526 | S713 | PSP | HIC1 ZBTB29 | PLAKFTAELGLsPDKAAEVLsQGAHLAAGPDGRtIDRFsPt |
| Q14674 | S1660 | PSP | ESPL1 ESP1 KIAA0165 | LSKAQKHRGSLEIADQLQGLsLQEMPGDVPLARIQRLFSFR |
| Q14676 | T4 | EPSD|PSP | MDC1 KIAA0170 NFBD1 | _________________MEDtQAIDWDVEEEEETEQsSESL |
| Q14676 | T98 | EPSD|PSP | MDC1 KIAA0170 NFBD1 | IEILAWDKAPILRDCGSLNGtQILRPPKVLsPGVSHRLRDQ |
| Q14683 | S957 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | DIKLPLSKGtMDDIsQEEGssQGEDsVsGsQRIssIYAREA |
| Q14683 | S966 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | tMDDIsQEEGssQGEDsVsGsQRIssIYAREALIEIDYGDL |
| Q14694 | S337 | GPS6|SIGNOR|EPSD|PSP | USP10 KIAA0190 | PESASPPADGTGSASGTLPVsQPKsWASLFHDSKPssssPV |
| Q14694 | T42 | GPS6|SIGNOR|EPSD|PSP | USP10 KIAA0190 | FVtPRssVELPPYSGTVLCGtQAVDKLPDGQEYQRIEFGVD |
| Q14839 | S1349 | EPSD|PSP | CHD4 | LARNLGKGKRIRKQVNYNDGsQEDRDWQDDQSDNQSDYSVA |
| Q15109 | S391 | EPSD|PSP | AGER RAGE | EERKAPENQEEEEERAELNQsEEPEAGEssTGGP_______ |
| Q15648 | S1134 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | MKSSKSEGSSSSKLSssMYSsQGssGssQsKNSsQsGGKPG |
| Q15648 | S1141 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | GSSSSKLSssMYSsQGssGssQsKNSsQsGGKPGssPItKH |
| Q15648 | S1147 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | LSssMYSsQGssGssQsKNSsQsGGKPGssPItKHGLSSGS |
| Q15648 | S816 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | tsDDCPAIGtPLRDSSSSGHsQSTLFDSDVFQTNNNENPYT |
| Q15648 | S872 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | DSPTNHFFHDGVDFNPDLLNsQsQsGFGEEYFDESsQSGDN |
| Q15648 | S874 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | PTNHFFHDGVDFNPDLLNsQsQsGFGEEYFDESsQSGDNDD |
| Q15648 | S887 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | PDLLNsQsQsGFGEEYFDESsQSGDNDDFKGFASQALNTLG |
| Q15648 | S953 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | IIsVAGKALAPADLMEHHsGsQGPLLTTGDLGKEKTQKRVK |
| Q15797 | S239 | SIGNOR|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | PADTPPPAYLPPEDPMTQDGsQPMDTNMMAPPLPSEINRGD |
| Q15831 | T363 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | STK11 LKB1 PJS | DLHGADEDEDLFDIEDDIIYtQDFtVPGQVPEEEASHNGQR |
| Q15831 | T367 | SIGNOR | STK11 LKB1 PJS | ADEDEDLFDIEDDIIYtQDFtVPGQVPEEEASHNGQRRGLP |
| Q15910 | S729 | SIGNOR | EZH2 KMT6 | GIFAKRAIQTGEELFFDYRYsQADALKYVGIEREMEIP___ |
| Q16204 | T434 | SIGNOR|EPSD|PSP | CCDC6 D10S170 TST1 | PRRSNsPDKFKRPtPPPSPNtQTPVQPPPPPPPPPMQPTVP |
| Q16656 | T259 | PSP | NRF1 | PWANVRSDVRTEEQKQRVSWtQALRTIVKNCYKQHGREDLL |
| Q16665 | S696 | SIGNOR|EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | VIEQTEKSHPRsPNVLsVALsQRTtVPEEELNPKILALQNA |
| Q4G0J3 | T440 | SIGNOR|PSP | LARP7 HDCMA18P | GVPQNTGMKNEKTANREECRtQEKVNATGPQFVSGVIVKII |
| Q504Q3 | S1003 | SIGNOR|PSP | PAN2 KIAA0710 USP52 | TLNEEEAELRSDGTKSTIKPsQMSVARITCVRGQGPNEGIP |
| Q587J8 | T145 | SIGNOR|PSP | KHDC3L C6orf221 ECAT1 | DVATQKAETQRSSIEVREAGtQRSVEVREAGtQRSVEVQEV |
| Q587J8 | T156 | SIGNOR|PSP | KHDC3L C6orf221 ECAT1 | SSIEVREAGtQRSVEVREAGtQRSVEVQEVGTQGSPVEVQE |
| Q5UIP0 | S1851 | EPSD|PSP | RIF1 | IVNFREEICDMDssEAMSLEsQEsPNENFKTVGPCLGDSKN |
| Q5VTR2 | S172 | SIGNOR|EPSD|PSP | RNF20 BRE1A | QEPAFSFLATLASSSSEEMEsQLQERVESSRRAVSQIVTVY |
| Q5VTR2 | S522 | EPSD|PSP | RNF20 BRE1A | REAQSDLNKTRLRsGsALLQsQsstEDPKDEPAELKPDSED |
| Q5VTR2 | S545 | EPSD|PSP | RNF20 BRE1A | stEDPKDEPAELKPDSEDLSsQSSASKAsQEDANEIKSKRD |
| Q5XUX0 | S278 | GPS6|SIGNOR|EPSD|PSP | FBXO31 FBX14 FBX31 PP2386 | LEDIFHEHMQELILMKFIYTsQYDNCLTYRRIYLPPSRPDD |
| Q6PCD5 | S46 | GPS6|EPSD|PSP | RFWD3 RNF201 | MASSQGGPALLQPVPADVVSsQGVPSILQPAPAEVISsQAT |
| Q6PCD5 | S63 | GPS6|EPSD|PSP | RFWD3 RNF201 | VVSsQGVPSILQPAPAEVISsQATPPLLQPAPQLSVDLTEV |
| Q6UWZ7 | S404 | SIGNOR|EPSD|PSP | ABRAXAS1 ABRA1 CCDC98 FAM175A UNQ496/PRO1013 | KMssPEtDEEIEKMKGFGEYsRsPtF_______________ |
| Q6UWZ7 | S406 | SIGNOR|EPSD|PSP | ABRAXAS1 ABRA1 CCDC98 FAM175A UNQ496/PRO1013 | ssPEtDEEIEKMKGFGEYsRsPtF_________________ |
| Q70CQ2 | S1751 | EPSD|PSP | USP34 KIAA0570 KIAA0729 | CKEYFWLLCKLVDNIHIKDAsQTTLLDLDALARHLADCIRS |
| Q70CQ2 | S718 | EPSD|PSP | USP34 KIAA0570 KIAA0729 | SEDPEHDISGEMNATHIAQGsQESCITRTGDFLGETIGNEL |
| Q7L7X3 | S990 | SIGNOR|EPSD|PSP | TAOK1 KIAA1361 MAP3K16 MARKK | RRTAsGGRTEQGMSRstsVTsQIsNGSHMsYT_________ |
| Q7L7X3 | T643 | SIGNOR|EPSD|PSP | TAOK1 KIAA1361 MAP3K16 MARKK | LLGRHNLEQDLVREELNKRQtQKDLEHAMLLRQHESMQELE |
| Q7L7X3 | T785 | SIGNOR|EPSD|PSP | TAOK1 KIAA1361 MAP3K16 MARKK | TRKLAILAEQYDHSINEMLStQALRLDEAQEAECQVLKMQL |
| Q7LG56 | S72 | SIGNOR|EPSD|PSP | RRM2B P53R2 | IWKMYKQAQASFWTAEEVDLsKDLPHWNKLKADEKYFISHI |
| Q7Z6Z7 | S2339 | EPSD|PSP | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | MDGEAETDSVVIAGQPEVLSsQEMQVENELEDLIDELLERD |
| Q7Z6Z7 | S2636 | EPSD|PSP | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | IARsDDELLDDFFHDQstAtsQAGTLSSIPTALTRWTEECK |
| Q7Z6Z7 | S3377 | EPSD|PSP | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | KETNCESDRERGNKACsPCssQssssGICTDFWDLLVKLDN |
| Q7Z6Z7 | S3695 | EPSD|PSP | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | KLKGKMQSRFDMAENVVIVAsQKRPLGGRELQLPSMSMLTS |
| Q7Z6Z7 | S3797 | EPSD|PSP | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | QMVREGQRARRQQQAATsEssQSEASVRREEsPMDVDQPsP |
| Q7Z6Z7 | S927 | EPSD|PSP | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | VHTCRVGQSEIRSISVNQWGsQLGLSVLSKLSQLYCSLVWE |
| Q86U44 | S43 | SIGNOR|PSP | METTL3 MTA70 | QRRRKQDsGHLDLRNPEAALsPtFRsDsPVPtAPtsGGPKP |
| Q86U86 | S948 | EPSD|PSP | PBRM1 BAF180 PB1 | AEKsEDssGAAGLSGLHRtYsQDCsFKNSMYHVGDYVYVEP |
| Q8IUQ4 | S19 | GPS6|SIGNOR|EPSD|PSP | SIAH1 HUMSIAH | __MSRQTATALPTGTSKCPPsQRVPALTGTTASNNDLASLF |
| Q8IW19 | S116 | GPS6|EPSD|PSP | APLF C2orf13 PALF XIP1 | YIFRILSIPSEVEMQCTLRNsQVLDEDNILNEtPKsPVINL |
| Q8IX03 | T1006 | EPSD|PSP | WWC1 KIAA0869 KIBRA | RTSLDLELDLQATRTWHSQLtQEISVLKELKEQLEQAKSHG |
| Q8IY92 | S1138 | EPSD|PSP | SLX4 BTBD12 KIAA1784 KIAA1987 | PEKSPSIDLTQSNPDHSSSRsQKSSSKLNEEDEVILLLDsD |
| Q8IY92 | S1271 | EPSD|PSP | SLX4 BTBD12 KIAA1784 KIAA1987 | TDTSWLVPATPLASRSRDCSsQTQISSLRSGLAVQAVtQHt |
| Q8IY92 | S1631 | EPSD|PSP | SLX4 BTBD12 KIAA1784 KIAA1987 | EDESQSSQPLLQAPHCQTLAsQTYKPSRAGVHAQQEATTGP |
| Q8IY92 | S1716 | EPSD|PSP | SLX4 BTBD12 KIAA1784 KIAA1987 | IPASQESVATSVDGSDSSLSsQSSSSCEFGAAFESAGEEEG |
| Q8IZL8 | S1033 | PSP | PELP1 HMX3 MNAR | GtEEERGADTAPTLAPEALPsQGEVEREGEsPAAGPPPQEL |
| Q8N0Z6 | S203 | SIGNOR | TTC5 | YILGNSYLSLYFSTGQNPKIsQQALSAYAQAEKVDRKASSN |
| Q8N163 | T454 | SIGNOR | CCAR2 DBC1 KIAA1967 | PTLEEWEALCQQKAAEAAPPtQEAQGEtEPTEQAPDALEQA |
| Q8N680 | S115 | EPSD|PSP | ZBTB2 KIAA1483 ZNF437 | LEQGIKFLHAYPLIQEASLAsQGAFSHPDQVFPLASSLYGI |
| Q8NEM0 | S322 | PSP | MCPH1 | LQRNIAGKVVTPDQKQAAGMsQETFEEKYRLsPtLsstKGH |
| Q8NHY2 | S387 | SIGNOR|EPSD|PSP | COP1 RFWD2 RNF200 | LEQCYFSTRMSRISDDSRTAsQLDEFQECLSKFTRYNSVRP |
| Q8TAQ2 | S969 | EPSD|PSP | SMARCC2 BAF170 | QHFQQMHQQQQQPPPALPPGsQPIPPTGAAGPPAVHGLAVA |
| Q8TAQ5 | S68 | SIGNOR|EPSD|PSP | ZNF420 | PSRCASKDLSPEKNTYETELsQWEMSDRLENCDLEESNSRD |
| Q8WVD3 | S124 | EPSD|PSP | RNF138 NARF HSD-4 HSD4 | SCKKYQDEYGVSSIIPNFQIsQDsVGNSNRSETstsDNtEt |
| Q8WYQ5 | S677 | SIGNOR|PSP | DGCR8 C22orf12 DGCRK6 LP4941 | CGKHTVRGWCKNKRVGKQLAsQKILQLLHPHVKNWGSLLRM |
| Q92499 | S377 | PSP | DDX1 | GKLNLSQVRFLVLDEADGLLsQGYSDFINRMHNQIPQVTSD |
| Q92499 | S671 | PSP | DDX1 | IWYNEMQLLSEIEEHLNCTIsQVEPDIKVPVDEFDGKVTYG |
| Q92547 | S1138 | iPTMNet|EPSD|PSP | TOPBP1 KIAA0259 | RVLEALRQSRQTVPDVNTEPsQNEQIIWDDPTAREERARLA |
| Q92547 | S492 | iPTMNet|EPSD|PSP | TOPBP1 KIAA0259 | FSKKDFAPSEKHEQADEDLLsQYENGSSTVVEAKTSEARPF |
| Q92547 | S554 | iPTMNet|EPSD|PSP | TOPBP1 KIAA0259 | QSSVSHCVPDVSTITEEGLFsQKSFLVLGFSNENESNIANI |
| Q92547 | S853 | iPTMNet|EPSD|PSP | TOPBP1 KIAA0259 | FKPSFDVKDALAALEtPGRPsQQKRKPstPLsEVIVKNLQL |
| Q92547 | T1062 | iPTMNet|EPSD|PSP | TOPBP1 KIAA0259 | NNKESAPSNGSGKNDSKGVLtQTLEMRENFQKQLQEIMSAT |
| Q92630 | S442 | GPS6|SIGNOR|EPSD|PSP | DYRK2 | LPGEDEGDQLACMIELLGMPsQKLLDAsKRAKNFVSSKGYP |
| Q92630 | T106 | GPS6|SIGNOR|EPSD|PSP | DYRK2 | GQIQVQQLFEDNSNKRTVLTtQPNGLTTVGKTGLPVVPERQ |
| Q92878 | S635 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RAD50 | LKRKEEQLsSyEDKLFDVCGsQDFESDLDRLKEEIEKSSKQ |
| Q92903 | T68 | GPS6 | CDS1 CDS | GDLDSRTDSDIPEIPPSSDRtPEILKKALSGLSSRWKNWWI |
| Q92905 | S320 | PSP | COPS5 CSN5 JAB1 | LAKATRDSCKTTIEAIHGLMsQVIKDKLFNQINIS______ |
| Q92945 | S274 | SIGNOR|EPSD|PSP | KHSRP FUBP2 | ETIKQLQERAGVKMILIQDGsQNtNVDKPLRIIGDPYKVQQ |
| Q92945 | S670 | SIGNOR|EPSD|PSP | KHSRP FUBP2 | EYYKKQAQVATGGGPGAPPGsQPDYSAAWAEYYRQQAAyYG |
| Q969H0 | S26 | SIGNOR|EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | LSVGsKRRRTGGsLRGNPSssQVDEEQMNRVVEEEQQQQLR |
| Q969R5 | S335 | EPSD|PSP | L3MBTL2 | MVESMKYPFRQGMRLEVVDKsQVSRTRMAVVDTVIGGRLRL |
| Q96J02 | S162 | SIGNOR | ITCH | LQLESEVVTNGETTCSENGVsLCLPRLECNSAISAHCNLCL |
| Q96KQ7 | S569 | EPSD|PSP | EHMT2 BAT8 C6orf30 G9A KMT1C NG36 | PRGDGVtPPAGtAAPAPPPLsQDVPGRADTSQPSARMRGHG |
| Q96RL1 | S205 | GPS6|EPSD|PSP | UIMC1 RAP80 RXRIP110 | HTEKTEEEPVsGssGsWDQssQPVFENVNVKSFDRCTGHSA |
| Q96RL1 | S402 | GPS6 | UIMC1 RAP80 RXRIP110 | KSLKEKLLLEEEPttsHGQssQGIVEEtsEEGNsVPAsQSV |
| Q96RU2 | S495 | SIGNOR|EPSD|PSP | USP28 KIAA1515 | SVHCSVSDQTSKEststEsssQDVESTFssPEDSLPKSKPL |
| Q96RU2 | S67 | SIGNOR|EPSD|PSP | USP28 KIAA1515 | SNGDITQAVSLLTDERVKEPsQDtVATEPSEVEGSAANKEV |
| Q96RU2 | S714 | SIGNOR|EPSD|PSP | USP28 KIAA1515 | EWEEEQSCKIPQMEsstNsssQDYSTsQEPSVASSHGVRCL |
| Q96RU2 | S720 | EPSD|PSP | USP28 KIAA1515 | SCKIPQMEsstNsssQDYSTsQEPSVASSHGVRCLSSEHAV |
| Q96S59 | S181 | EPSD|PSP | RANBP9 RANBPM | QEtPLPRSWsPKDKFsYIGLsQNNLRVHYKGHGKTPKDAAS |
| Q96S59 | S550 | EPSD|PSP | RANBP9 RANBPM | NKHQssNLNVPELNSINMSRsQQVNNFTSNDVDMETDHYSN |
| Q96S59 | S603 | EPSD|PSP | RANBP9 RANBPM | GSSKHDHEMEDCDtEMEVDSsQLRRQLCGGsQAAIERMIHF |
| Q96SB4 | S408 | PSP | SRPK1 | VQNLNQESSFLSSQNGDSSTsQETDSCTPITSEVSDTMVCQ |
| Q96SB4 | T326 | PSP | SRPK1 | QEEsEsPVERPLKENPPNKMtQEKLEEsstIGQDQtLMERD |
| Q96SD1 | S503 | SIGNOR|EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | DGDVPQWEVFFKRNDEITDEsLENFPSSTVAGGsQsPKLFS |
| Q96SD1 | S516 | GPS6|SIGNOR|EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | NDEITDEsLENFPSSTVAGGsQsPKLFSDsDGESTHISsQN |
| Q96SD1 | S525 | iPTMNet | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | ENFPSSTVAGGsQsPKLFSDsDGESTHISsQNSsQSTHITE |
| Q96SD1 | S534 | GPS6 | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | GGsQsPKLFSDsDGESTHISsQNSsQSTHITEQGsQGWDsQ |
| Q96SD1 | S538 | GPS6 | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | sPKLFSDsDGESTHISsQNSsQSTHITEQGsQGWDsQSDTV |
| Q96SD1 | S645 | GPS6|SIGNOR|EPSD|PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | SSETHIPEEKSLLNLSTNADsQsssDFEVPstPEAELPKRE |
| Q96SD1 | S647 | PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | ETHIPEEKSLLNLSTNADsQsssDFEVPstPEAELPKREHL |
| Q96SD1 | S648 | PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | THIPEEKSLLNLSTNADsQsssDFEVPstPEAELPKREHLQ |
| Q96SD1 | S649 | PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | HIPEEKSLLNLSTNADsQsssDFEVPstPEAELPKREHLQY |
| Q96SD1 | T656 | PSP | DCLRE1C ARTEMIS ASCID SCIDA SNM1C | LLNLSTNADsQsssDFEVPstPEAELPKREHLQYLYEKLAT |
| Q96T60 | S114 | GPS6|SIGNOR|EPSD|PSP | PNKP | YLVNGLHPLTLRWEEtRtPEsQPDtPPGtPLVsQDEKRDAE |
| Q96T60 | S126 | GPS6|SIGNOR|EPSD|PSP | PNKP | WEEtRtPEsQPDtPPGtPLVsQDEKRDAELPKKRMRKsNPG |
| Q99504 | S266 | EPSD|PSP | EYA3 | APAPAAQRLssGDPstsPsLsQttPsKDtDDQSRKNMTSKN |
| Q99638 | S272 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RAD9A | KDSLLDGHFVLAtLsDtDsHsQDLGsPERHQPVPQLQAHSt |
| Q99708 | S664 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBBP8 CTIP | NNQDVSFENIQWSIDPGADLsQYKMDVTVIDTKDGSQSKLG |
| Q99708 | S745 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RBBP8 CTIP | EDMFDRtTHEEYESCLADSFsQAADEEEELSTATKKLHTHG |
| Q99728 | T714 | GPS6 | BARD1 | LVTAGGGQILSRKPKPDSDVtQTINTVAYHARPDSDQRFCt |
| Q99728 | T734 | GPS6 | BARD1 | tQTINTVAYHARPDSDQRFCtQYIIYEDLCNYHPERVRQGK |
| Q99801 | T134 | SIGNOR|EPSD|PSP | NKX3-1 NKX3.1 NKX3A | PRLPQTPKQPQKRSRAAFSHtQVIELERKFSHQKYLSAPER |
| Q99801 | T166 | SIGNOR|EPSD|PSP | NKX3-1 NKX3.1 NKX3A | QKYLSAPERAHLAKNLKLTEtQVKIWFQNRRYKTKRKQLss |
| Q9BQ15 | T117 | GPS6|SIGNOR|EPSD|PSP | NABP2 OBFC2B SSB1 LP3587 | EFCMVYSEVPNFSEPNPEYStQQAPNKAVQNDSNPSAsQPT |
| Q9BUR4 | S64 | SIGNOR|EPSD|PSP | WRAP53 TCAB1 WDR79 | PPERGDPPRLsPDPVAGSAVsQELREGDPVsLstPLEtEFG |
| Q9BW19 | S26 | SIGNOR|PSP | KIFC1 HSET KNSL2 | sPLLEVKGNIELKRPLIKAPsQLPLsGsRLKRRPDQMEDGL |
| Q9BXS6 | S124 | EPSD|PSP | NUSAP1 ANKT BM-037 PRO0310 | NHsEIKISNPTEFQNHEKQEsQDLRATAKVPsPPDEHQEAE |
| Q9BXW9 | S1257 | GPS6|ELM|iPTMNet|EPSD | FANCD2 FACD | VMMAELEKTVKKIEPGTAADsQQIHEEKLLYWNMAVRDFSI |
| Q9BXW9 | S1401 | GPS6|SIGNOR | FANCD2 FACD | REAFWLGNLKNRDLQGEEIKsQNsQEstADEsEDDMSsQAS |
| Q9BXW9 | S1404 | GPS6|SIGNOR|EPSD | FANCD2 FACD | FWLGNLKNRDLQGEEIKsQNsQEstADEsEDDMSsQASKsK |
| Q9BXW9 | S1407 | SIGNOR | FANCD2 FACD | GNLKNRDLQGEEIKsQNsQEstADEsEDDMSsQASKsKAtE |
| Q9BXW9 | S1418 | GPS6 | FANCD2 FACD | EIKsQNsQEstADEsEDDMSsQASKsKAtEDGEEDEVsAGE |
| Q9BXW9 | S222 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FANCD2 FACD | IAPENLQHDIITSLPEILGDsQHADVGKELSDLLIENTSLT |
| Q9BXW9 | S717 | EPSD|PSP | FANCD2 FACD | INLLPLLFsQDFAKDGGPVTsQESGQKLVSPLCLAPYFRLL |
| Q9BXW9 | T691 | EPSD|PSP | FANCD2 FACD | VPEGDFPFPVKALYGLEEyDtQDGIAINLLPLLFsQDFAKD |
| Q9H2K8 | S324 | GPS6|EPSD | TAOK3 DPK JIK KDS MAP3K18 | QyRKMKKILFQETRNGPLNEsQEDEEDsEHGTsLNREMDSL |
| Q9H2K8 | S359 | EPSD|PSP | TAOK3 DPK JIK KDS MAP3K18 | REMDSLGSNHSIPSMSVSTGsQSSSVNSMQEVMDESSSELV |
| Q9H2K8 | S551 | EPSD|PSP | TAOK3 DPK JIK KDS MAP3K18 | KKFQQQILAQQKKDLTTFLEsQKKQYKICKEKIKEEMNEDH |
| Q9H3D4 | S477 | SIGNOR | TP63 KET P63 P73H P73L TP73L | ssYGNssPPLNKMNSMNKLPsVsQLINPQQRNALtPTTIPD |
| Q9H3D4 | S479 | EPSD|PSP | TP63 KET P63 P73H P73L TP73L | YGNssPPLNKMNSMNKLPsVsQLINPQQRNALtPTTIPDGM |
| Q9H3D4 | S560 | SIGNOR | TP63 KET P63 P73H P73L TP73L | PPPYPTDCSIVSFLARLGCSsCLDYFTTQGLTTIYQIEHYS |
| Q9H3D4 | T491 | SIGNOR | TP63 KET P63 P73H P73L TP73L | SMNKLPsVsQLINPQQRNALtPTTIPDGMGANIPMMGTHMP |
| Q9H7Z6 | T392 | PSP | KAT8 MOF MYST1 PP7073 | ILRDFRGTLSIKDLSQMTSItQNDIISTLQSLNMVKYWKGQ |
| Q9H9Q4 | S251 | SIGNOR|EPSD|PSP | NHEJ1 XLF | KHQGAGDPHTSNSAsLQGIDsQCVNQPEQLVSsAPtLSAPE |
| Q9HAU4 | S384 | SIGNOR|PSP | SMURF2 | TVPRYKRDLVQKLKILRQELsQQQPQAGHCRIEVSREEIFE |
| Q9HB75 | T788 | SIGNOR|PSP | PIDD1 LRDD PIDD | RGAGLSLAPLNLGDAETGFLtQSNLLSVAGRLGLDWPAVAL |
| Q9NQS1 | S135 | GPS6|SIGNOR|EPSD|PSP | AVEN | VSNWDRyQDIEKEVNNESGEsQRGTDFSVLLSSAGDSFSQF |
| Q9NQS1 | S308 | GPS6|SIGNOR|EPSD|PSP | AVEN | LLLNLDAPIKEGDNILPDQtsQDLKSKEDGEVVQEEEVCAK |
| Q9NRR5 | S318 | SIGNOR|PSP | UBQLN4 C1orf6 CIP75 UBIN | REQFGNNPFSsLAGNSDssssQPLRTENREPLPNPWSPSPP |
| Q9NS23 | S135 | SIGNOR|EPSD|PSP | RASSF1 RDA32 | PAVERDTNVDEPVEWETPDLsQAEIEQKIKEYNAQINSNLF |
| Q9NS91 | S403 | EPSD|PSP | RAD18 RNF73 | KLSSVCMGQEDNMTSVTNHFsQsKLDsPEELEPDREEDSSS |
| Q9NUW8 | S365 | EPSD|PSP | TDP1 | HDLSETNVYLIGSTPGRFQGsQKDNWGHFRLKKLLKDHASS |
| Q9NUW8 | S563 | EPSD|PSP | TDP1 | FLPSAFGLDSFKVKQKFFAGsQEPMATFPVPYDLPPELYGS |
| Q9NUW8 | S81 | SIGNOR|EPSD|PSP | TDP1 | SPVKFSNTDSVLPPKRQKSGsQEDLGWCLSSSDDELQPEMP |
| Q9NVI1 | S1121 | EPSD|PSP | FANCI KIAA1794 | WLITKLKGQVsQEtLsEEAssQAtLPNQPVEKAIIMQLGTL |
| Q9NVI1 | S556 | EPSD|PSP | FANCI KIAA1794 | AVAGFLLLLKNFKVLGSLSSsQCsQSLSVsQVHVDVHSHYN |
| Q9NVI1 | S559 | EPSD|PSP | FANCI KIAA1794 | GFLLLLKNFKVLGSLSSsQCsQSLSVsQVHVDVHSHYNSVA |
| Q9NVI1 | S730 | SIGNOR|EPSD|PSP | FANCI KIAA1794 | TNRMIKSELEDFELDKsADFsQSTSIGIKNNICAFLVMGVC |
| Q9NVI1 | S972 | EPSD|PSP | FANCI KIAA1794 | tQRTAFQIRQFQRSLLNLLSsQEEDFNSKEALLLVTVLTSL |
| Q9NY61 | S189 | SIGNOR|EPSD|PSP | AATF CHE1 DED HSPC277 | SSEEEEDEESGMEEGDDAEDsQGESEEDRAGDRNsEDDGVV |
| Q9NZM5 | S233 | SIGNOR|EPSD|PSP | NOP53 GLT GLTSCR2 PICT1 | FLEQTKKKGVKRPARLHTKPsQAPAVEVAPAGASYNPSFED |
| Q9NZM5 | T289 | SIGNOR|EPSD|PSP | NOP53 GLT GLTSCR2 PICT1 | QKEAEKLERQLALPATEQAAtQESTFQELCEGLLEESDGEG |
| Q9UBU7 | S502 | SIGNOR|EPSD|PSP | DBF4 ASK DBF4A ZDBF1 | YKCNIQASVHVSDFSTDNSGsQPKQKsDtVLFPAKDLKEKD |
| Q9UBU7 | S539 | SIGNOR|EPSD|PSP | DBF4 ASK DBF4A ZDBF1 | KEKDLHSIFTHDSGLITINSsQEHLTVQAKAPFHtPPEEPN |
| Q9UBU7 | T449 | SIGNOR|EPSD|PSP | DBF4 ASK DBF4A ZDBF1 | KMSNKCSMLSTAEDDIRQNFtQLPLHKNKQECILDISEHTL |
| Q9UER7 | S564 | SIGNOR|EPSD|PSP | DAXX BING2 DAP6 | DAESNGEQPEELTLEEESPVsQLFELEIEALPLDTPSSVET |
| Q9UGP5 | T204 | SIGNOR|EPSD|PSP | POLL | EAPNTQAQPISDDEASDGEEtQVSAADLEALISGHYPTSLE |
| Q9UMS4 | S149 | PSP | PRPF19 NMP200 PRP19 SNEV | EALATLKPQAGLIVPQAVPssQPSVVGAGEPMDLGELVGMT |
| Q9UPV0 | S186 | GPS6|EPSD | CEP164 KIAA1052 NPHP15 | SVSLGSSVESGRQLGELMLPsQGLKTSAYTKGLLGSIyEDK |
| Q9UQE7 | S1083 | SIGNOR|EPSD|PSP | SMC3 BAM BMH CSPG6 SMC3L1 | EGsQsQDEGEGsGEsERGsGsQssVPsVDQFTGVGIRVSFT |
| Q9UQR1 | S202 | GPS6|SIGNOR|EPSD|PSP | ZNF148 ZBP89 | TNYHLQRHVFIHtGEKPFQCsQCDMRFIQKYLLQRHEKIHT |
| Q9Y297 | S158 | SIGNOR|PSP | BTRC BTRCP FBW1A FBXW1A | VKYFEQWSESDQVEFVEHLIsQMCHYQHGHINSYLKPMLQR |
| Q9Y2K7 | T632 | EPSD|PSP | KDM2A CXXC8 FBL11 FBL7 FBXL11 JHDM1A KIAA1004 | PRLPHSVTCSLCGEVDQNEEtQDFEKKLMECCICNEIVHPG |
| Q9Y4E8 | S678 | EPSD|PSP | USP15 KIAA0529 | TDEPDDESSQDQELPSENENsQSEDSVGGDNDSENGLCTED |
| Q9Y4P3 | T433 | GPS6|EPSD | TBL2 WBSCR13 UNQ563/PRO1125 | QGHLKRASNESTRQRLQQQLtQAQETLKSLGALKK______ |
| Q9Y6D9 | S214 | EPSD|PSP | MAD1L1 MAD1 TXBP181 | LDLQHKKCQEANQKIQELQAsQEARADHEQQIKDLEQKLSL |
| Q9Y6K9 | S85 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | IKBKG FIP3 NEMO | IRQsNQILRERCEELLHFQAsQREEKEFLMCKFQEARKLVE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.462297e-14 | 13.263 | 1 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.460699e-14 | 13.127 | 1 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.401101e-13 | 12.854 | 1 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.497824e-13 | 12.260 | 1 | 1 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.126765e-12 | 11.948 | 1 | 1 |
| DNA Repair | R-HSA-73894 | 5.034084e-12 | 11.298 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.552026e-12 | 11.020 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.627743e-11 | 10.440 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.902712e-11 | 10.310 | 1 | 1 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.248069e-11 | 10.204 | 1 | 1 |
| M Phase | R-HSA-68886 | 5.361429e-10 | 9.271 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.073298e-09 | 8.969 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.045125e-08 | 7.981 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.339375e-08 | 7.273 | 1 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.339375e-08 | 7.273 | 1 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.340210e-08 | 7.198 | 1 | 1 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.962920e-08 | 7.048 | 1 | 1 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.001908e-07 | 6.999 | 1 | 1 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.126532e-07 | 6.948 | 1 | 1 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.144964e-07 | 6.941 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.534621e-07 | 6.596 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.532282e-07 | 6.452 | 1 | 1 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.501906e-07 | 6.347 | 1 | 1 |
| Meiosis | R-HSA-1500620 | 4.995484e-07 | 6.301 | 1 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.081497e-06 | 5.966 | 1 | 1 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.171262e-06 | 5.931 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.242169e-06 | 5.906 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.292290e-06 | 5.889 | 1 | 1 |
| Diseases of DNA repair | R-HSA-9675135 | 1.398250e-06 | 5.854 | 1 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.769763e-06 | 5.752 | 1 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.769763e-06 | 5.752 | 1 | 1 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.769763e-06 | 5.752 | 1 | 1 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.769763e-06 | 5.752 | 1 | 1 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.102415e-06 | 5.677 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.818616e-06 | 5.550 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.174111e-06 | 5.498 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.296672e-06 | 5.482 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.466411e-06 | 5.350 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.366607e-06 | 5.270 | 1 | 1 |
| Mitotic Prophase | R-HSA-68875 | 5.579025e-06 | 5.253 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.893977e-06 | 5.103 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.029929e-06 | 5.095 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.091434e-06 | 5.041 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.197697e-06 | 5.036 | 1 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.829222e-06 | 5.007 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.797418e-06 | 5.009 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.501223e-05 | 4.824 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.788448e-05 | 4.748 | 1 | 1 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.832796e-05 | 4.737 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.238092e-05 | 4.650 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.360503e-05 | 4.627 | 1 | 1 |
| Mitotic Anaphase | R-HSA-68882 | 2.386910e-05 | 4.622 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.671374e-05 | 4.573 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.073743e-05 | 4.512 | 1 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.219536e-05 | 4.492 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.598361e-05 | 4.337 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.660150e-05 | 4.332 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.755453e-05 | 4.323 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.761261e-05 | 4.239 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.022555e-05 | 4.154 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.945317e-05 | 4.158 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.945317e-05 | 4.158 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.437171e-05 | 4.129 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.437171e-05 | 4.129 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.109770e-05 | 4.091 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.537950e-05 | 4.069 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.999815e-05 | 4.000 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.186826e-04 | 3.926 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.252326e-04 | 3.902 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.490549e-04 | 3.827 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.565511e-04 | 3.805 | 1 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.569889e-04 | 3.804 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.664725e-04 | 3.779 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.005102e-04 | 3.698 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.171665e-04 | 3.663 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.498580e-04 | 3.602 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.503716e-04 | 3.601 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.513718e-04 | 3.600 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.606162e-04 | 3.584 | 1 | 0 |
| DNA methylation | R-HSA-5334118 | 2.824376e-04 | 3.549 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.956831e-04 | 3.529 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.956831e-04 | 3.529 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.454855e-04 | 3.462 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.751498e-04 | 3.426 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.799674e-04 | 3.420 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.183245e-04 | 3.378 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.259690e-04 | 3.371 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.391655e-04 | 3.357 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.892546e-04 | 3.310 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.656163e-04 | 3.332 | 1 | 1 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.269469e-04 | 3.278 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.776183e-04 | 3.238 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.191587e-04 | 3.208 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.278609e-04 | 3.202 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.238725e-04 | 3.205 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.909812e-04 | 3.228 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.100625e-04 | 3.149 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.301242e-04 | 3.137 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.701003e-04 | 3.113 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.759101e-04 | 3.110 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.374922e-04 | 3.077 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.577898e-04 | 3.067 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.749135e-04 | 3.058 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.882166e-04 | 3.051 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.037963e-04 | 3.044 | 1 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.059878e-03 | 2.975 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.105659e-03 | 2.956 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.192570e-03 | 2.924 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.145465e-03 | 2.941 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.149042e-03 | 2.940 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.205195e-03 | 2.919 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.219967e-03 | 2.914 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.244744e-03 | 2.905 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.276162e-03 | 2.894 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.334861e-03 | 2.875 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.358039e-03 | 2.867 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.446939e-03 | 2.840 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.419897e-03 | 2.848 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.419897e-03 | 2.848 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.491804e-03 | 2.826 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.492104e-03 | 2.826 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.709878e-03 | 2.767 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.749187e-03 | 2.757 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.780595e-03 | 2.749 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.795122e-03 | 2.746 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.987077e-03 | 2.702 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.987077e-03 | 2.702 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.009685e-03 | 2.697 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.875490e-03 | 2.727 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.948211e-03 | 2.710 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.948211e-03 | 2.710 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.052094e-03 | 2.688 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.079512e-03 | 2.682 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.079512e-03 | 2.682 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.211287e-03 | 2.655 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.250362e-03 | 2.648 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.269309e-03 | 2.644 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.477582e-03 | 2.606 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.273907e-03 | 2.643 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.321521e-03 | 2.634 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.423501e-03 | 2.616 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.291038e-03 | 2.640 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.486373e-03 | 2.604 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.614354e-03 | 2.583 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.854837e-03 | 2.544 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.921968e-03 | 2.534 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.921968e-03 | 2.534 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.938365e-03 | 2.532 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.962318e-03 | 2.528 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.979750e-03 | 2.526 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.979750e-03 | 2.526 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.046541e-03 | 2.516 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.278794e-03 | 2.484 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.225000e-03 | 2.491 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.472265e-03 | 2.459 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 3.337821e-03 | 2.477 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.758121e-03 | 2.425 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.829995e-03 | 2.417 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.985414e-03 | 2.400 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.993728e-03 | 2.399 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.998178e-03 | 2.398 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.078882e-03 | 2.389 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.081218e-03 | 2.389 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.231868e-03 | 2.373 | 1 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.243122e-03 | 2.372 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.275635e-03 | 2.369 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.380965e-03 | 2.358 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.659382e-03 | 2.332 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.839491e-03 | 2.315 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.411178e-03 | 2.267 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.411178e-03 | 2.267 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.118115e-03 | 2.291 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.108642e-03 | 2.292 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.144784e-03 | 2.211 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.567182e-03 | 2.183 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.857495e-03 | 2.164 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.925541e-03 | 2.160 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.049090e-03 | 2.152 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.150542e-03 | 2.146 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.380702e-03 | 2.132 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.451968e-03 | 2.128 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.707213e-03 | 2.113 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.853279e-03 | 2.105 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.884954e-03 | 2.103 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.244347e-03 | 2.084 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.300891e-03 | 2.081 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 8.394886e-03 | 2.076 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.394886e-03 | 2.076 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.846973e-03 | 2.053 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.846973e-03 | 2.053 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.865553e-03 | 2.052 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.866491e-03 | 2.052 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.833651e-03 | 2.007 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.037538e-02 | 1.984 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.057214e-02 | 1.976 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.057412e-02 | 1.976 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.074909e-02 | 1.969 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.087007e-02 | 1.964 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.098974e-02 | 1.959 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.165715e-02 | 1.933 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.180008e-02 | 1.928 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.191676e-02 | 1.924 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.191676e-02 | 1.924 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.257515e-02 | 1.900 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.276409e-02 | 1.894 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.349117e-02 | 1.870 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.381089e-02 | 1.860 | 1 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.396683e-02 | 1.855 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.398170e-02 | 1.854 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.604700e-02 | 1.795 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.604700e-02 | 1.795 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.604700e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.604700e-02 | 1.795 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.559423e-02 | 1.807 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.546288e-02 | 1.811 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.546288e-02 | 1.811 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.425449e-02 | 1.846 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.553110e-02 | 1.809 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.515821e-02 | 1.819 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.459666e-02 | 1.836 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.579052e-02 | 1.802 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.515821e-02 | 1.819 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.541277e-02 | 1.812 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.626028e-02 | 1.789 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.745675e-02 | 1.758 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.843247e-02 | 1.734 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.845999e-02 | 1.734 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.866295e-02 | 1.729 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.866295e-02 | 1.729 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.932767e-02 | 1.714 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.979468e-02 | 1.703 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.979468e-02 | 1.703 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.091483e-02 | 1.680 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.169220e-02 | 1.664 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.171289e-02 | 1.663 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.171289e-02 | 1.663 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.186326e-02 | 1.660 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.186326e-02 | 1.660 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.186939e-02 | 1.660 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.186939e-02 | 1.660 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.248488e-02 | 1.648 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.248488e-02 | 1.648 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.248488e-02 | 1.648 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.291433e-02 | 1.640 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.358933e-02 | 1.627 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.560378e-02 | 1.592 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.635739e-02 | 1.579 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.524392e-02 | 1.598 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.676068e-02 | 1.573 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.717820e-02 | 1.566 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.737961e-02 | 1.563 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.737961e-02 | 1.563 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.775933e-02 | 1.557 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.775959e-02 | 1.557 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.819431e-02 | 1.550 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.819431e-02 | 1.550 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.860560e-02 | 1.544 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.860560e-02 | 1.544 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.891326e-02 | 1.539 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.920954e-02 | 1.534 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.989303e-02 | 1.524 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.008765e-02 | 1.522 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.061357e-02 | 1.514 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.144302e-02 | 1.502 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.160798e-02 | 1.500 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.160798e-02 | 1.500 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.330057e-02 | 1.478 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.330057e-02 | 1.478 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.330057e-02 | 1.478 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.330057e-02 | 1.478 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.332858e-02 | 1.477 | 1 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.422493e-02 | 1.466 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.477799e-02 | 1.459 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.518076e-02 | 1.454 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.038025e-02 | 1.394 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.038025e-02 | 1.394 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.038025e-02 | 1.394 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.896052e-02 | 1.409 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.006551e-02 | 1.397 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.222126e-02 | 1.374 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.222126e-02 | 1.374 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.958212e-02 | 1.403 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.689205e-02 | 1.433 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.550243e-02 | 1.450 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.751638e-02 | 1.426 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.027799e-02 | 1.395 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.056675e-02 | 1.392 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.975420e-02 | 1.401 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.870096e-02 | 1.412 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.875173e-02 | 1.412 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.701681e-02 | 1.432 | 1 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.222126e-02 | 1.374 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.038025e-02 | 1.394 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.816226e-02 | 1.418 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.339108e-02 | 1.363 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.440037e-02 | 1.353 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.485040e-02 | 1.348 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.486650e-02 | 1.348 | 1 | 1 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.510240e-02 | 1.346 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.517058e-02 | 1.345 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.581994e-02 | 1.339 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.581994e-02 | 1.339 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.587955e-02 | 1.338 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.587955e-02 | 1.338 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.693551e-02 | 1.328 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.712116e-02 | 1.327 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.780903e-02 | 1.320 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.780903e-02 | 1.320 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.851040e-02 | 1.314 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.862163e-02 | 1.313 | 1 | 1 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.862163e-02 | 1.313 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.903376e-02 | 1.310 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.910224e-02 | 1.309 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.965868e-02 | 1.304 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.965868e-02 | 1.304 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.992262e-02 | 1.302 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.992262e-02 | 1.302 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.013136e-02 | 1.300 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.223754e-02 | 1.282 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.223754e-02 | 1.282 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.342518e-02 | 1.272 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.387858e-02 | 1.269 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.460741e-02 | 1.263 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.488109e-02 | 1.188 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.755166e-02 | 1.240 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.755166e-02 | 1.240 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.755166e-02 | 1.240 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.061077e-02 | 1.217 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.965567e-02 | 1.224 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.663197e-02 | 1.176 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.693018e-02 | 1.245 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.693018e-02 | 1.245 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.693018e-02 | 1.245 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.093855e-02 | 1.149 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.664080e-02 | 1.176 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.021116e-02 | 1.220 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.028692e-02 | 1.220 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.915408e-02 | 1.228 | 1 | 1 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.211475e-02 | 1.207 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.093855e-02 | 1.149 | 1 | 1 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.474330e-02 | 1.189 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.720881e-02 | 1.173 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.211475e-02 | 1.207 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.751015e-02 | 1.171 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.179409e-02 | 1.209 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.061077e-02 | 1.217 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.682771e-02 | 1.245 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.915214e-02 | 1.228 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.061077e-02 | 1.217 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.824408e-02 | 1.166 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.670176e-02 | 1.176 | 1 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.939015e-02 | 1.226 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.843724e-02 | 1.165 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.485559e-02 | 1.188 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.755166e-02 | 1.240 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.093855e-02 | 1.149 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.824445e-02 | 1.166 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.885283e-02 | 1.162 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.103443e-02 | 1.149 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.103443e-02 | 1.149 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.103443e-02 | 1.149 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.103443e-02 | 1.149 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.344467e-02 | 1.134 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.344467e-02 | 1.134 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.383511e-02 | 1.132 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.388291e-02 | 1.131 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.388291e-02 | 1.131 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.388291e-02 | 1.131 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.412631e-02 | 1.130 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.470618e-02 | 1.127 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.640478e-02 | 1.117 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.640478e-02 | 1.117 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.727713e-02 | 1.112 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.727713e-02 | 1.112 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.727713e-02 | 1.112 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.727713e-02 | 1.112 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.984184e-02 | 1.098 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.086437e-02 | 1.092 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.086437e-02 | 1.092 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.157828e-02 | 1.088 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.270282e-02 | 1.082 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.270282e-02 | 1.082 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.272184e-02 | 1.082 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.318677e-02 | 1.080 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.318677e-02 | 1.080 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.335550e-02 | 1.079 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.335550e-02 | 1.079 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.357365e-02 | 1.078 | 1 | 1 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.357365e-02 | 1.078 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.471407e-02 | 1.072 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.676651e-02 | 1.062 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 8.829199e-02 | 1.054 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 8.829199e-02 | 1.054 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.829199e-02 | 1.054 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.885670e-02 | 1.051 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.885670e-02 | 1.051 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.914016e-02 | 1.050 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.914016e-02 | 1.050 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.914016e-02 | 1.050 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.157125e-02 | 1.038 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.157125e-02 | 1.038 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.229421e-02 | 1.035 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 9.229421e-02 | 1.035 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 9.229421e-02 | 1.035 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 9.229421e-02 | 1.035 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.222140e-01 | 0.913 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.222140e-01 | 0.913 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.222140e-01 | 0.913 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.222140e-01 | 0.913 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.222140e-01 | 0.913 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.222140e-01 | 0.913 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.222140e-01 | 0.913 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.222140e-01 | 0.913 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.222140e-01 | 0.913 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.222140e-01 | 0.913 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 9.674145e-02 | 1.014 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.056018e-01 | 0.976 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.056018e-01 | 0.976 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.056018e-01 | 0.976 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.056018e-01 | 0.976 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.056018e-01 | 0.976 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.056018e-01 | 0.976 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.725578e-02 | 1.012 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.234408e-01 | 0.909 | 1 | 1 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.013599e-01 | 0.994 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.030529e-01 | 0.987 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.152970e-01 | 0.938 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.259074e-02 | 1.033 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.144800e-01 | 0.941 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.128103e-01 | 0.948 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.052418e-01 | 0.978 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.052418e-01 | 0.978 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.036510e-01 | 0.984 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.144800e-01 | 0.941 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.114118e-01 | 0.953 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.114118e-01 | 0.953 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.114118e-01 | 0.953 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.032260e-01 | 0.986 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.234408e-01 | 0.909 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.120503e-01 | 0.951 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.071125e-01 | 0.970 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.030529e-01 | 0.987 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.052418e-01 | 0.978 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.263107e-02 | 1.033 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.725578e-02 | 1.012 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.024106e-01 | 0.990 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.154244e-01 | 0.938 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.114118e-01 | 0.953 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.122363e-01 | 0.950 | 1 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.146907e-01 | 0.940 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.234288e-01 | 0.909 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.207596e-01 | 0.918 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.259074e-02 | 1.033 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.144800e-01 | 0.941 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.035486e-01 | 0.985 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.146907e-01 | 0.940 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.013599e-01 | 0.994 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.013599e-01 | 0.994 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.234408e-01 | 0.909 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.237123e-01 | 0.908 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.237821e-01 | 0.907 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.263810e-01 | 0.898 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.263810e-01 | 0.898 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.279149e-01 | 0.893 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.279149e-01 | 0.893 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.279149e-01 | 0.893 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.279149e-01 | 0.893 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.279149e-01 | 0.893 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.290527e-01 | 0.889 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.290527e-01 | 0.889 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.314303e-01 | 0.881 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.314303e-01 | 0.881 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.314303e-01 | 0.881 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.329895e-01 | 0.876 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.348031e-01 | 0.870 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.348031e-01 | 0.870 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.348031e-01 | 0.870 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.361143e-01 | 0.866 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.384123e-01 | 0.859 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.391975e-01 | 0.856 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.391975e-01 | 0.856 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 1.391975e-01 | 0.856 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.391975e-01 | 0.856 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 1.391975e-01 | 0.856 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.391975e-01 | 0.856 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.391975e-01 | 0.856 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.419958e-01 | 0.848 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.419958e-01 | 0.848 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.425700e-01 | 0.846 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.425700e-01 | 0.846 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.425700e-01 | 0.846 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.425700e-01 | 0.846 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.436406e-01 | 0.843 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.436406e-01 | 0.843 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.436406e-01 | 0.843 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.436406e-01 | 0.843 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.436406e-01 | 0.843 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 1.441806e-01 | 0.841 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.441806e-01 | 0.841 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.447964e-01 | 0.839 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.462808e-01 | 0.835 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.294979e-01 | 0.639 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.294979e-01 | 0.639 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.294979e-01 | 0.639 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.294979e-01 | 0.639 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.294979e-01 | 0.639 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.294979e-01 | 0.639 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.294979e-01 | 0.639 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.294979e-01 | 0.639 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.294979e-01 | 0.639 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.294979e-01 | 0.639 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.294979e-01 | 0.639 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.847704e-01 | 0.733 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.847704e-01 | 0.733 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.847704e-01 | 0.733 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.847704e-01 | 0.733 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 1.847704e-01 | 0.733 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.236750e-01 | 0.490 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.236750e-01 | 0.490 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.236750e-01 | 0.490 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.236750e-01 | 0.490 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.236750e-01 | 0.490 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.236750e-01 | 0.490 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.236750e-01 | 0.490 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.236750e-01 | 0.490 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.236750e-01 | 0.490 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.236750e-01 | 0.490 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.236750e-01 | 0.490 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.320651e-01 | 0.634 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.320651e-01 | 0.634 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.320651e-01 | 0.634 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.320651e-01 | 0.634 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.746889e-01 | 0.758 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.585536e-01 | 0.800 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.585536e-01 | 0.800 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.585536e-01 | 0.800 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.585536e-01 | 0.800 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.585536e-01 | 0.800 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.585536e-01 | 0.800 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.585536e-01 | 0.800 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.585536e-01 | 0.800 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.585536e-01 | 0.800 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.073861e-01 | 0.683 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.073861e-01 | 0.683 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 2.073861e-01 | 0.683 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.799808e-01 | 0.553 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.799808e-01 | 0.553 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.799808e-01 | 0.553 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.799808e-01 | 0.553 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.799808e-01 | 0.553 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.063458e-01 | 0.391 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.063458e-01 | 0.391 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.063458e-01 | 0.391 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.063458e-01 | 0.391 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 4.063458e-01 | 0.391 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.413007e-01 | 0.617 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.100495e-01 | 0.678 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.100495e-01 | 0.678 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.276596e-01 | 0.485 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.276596e-01 | 0.485 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 3.276596e-01 | 0.485 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.276596e-01 | 0.485 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.276596e-01 | 0.485 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.842826e-01 | 0.735 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.842826e-01 | 0.735 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.842826e-01 | 0.735 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.626324e-01 | 0.789 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.626324e-01 | 0.789 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.760290e-01 | 0.559 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.760290e-01 | 0.559 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.760290e-01 | 0.559 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.760290e-01 | 0.559 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.760290e-01 | 0.559 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.373720e-01 | 0.625 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.373720e-01 | 0.625 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.066333e-01 | 0.685 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.654619e-01 | 0.576 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.112009e-01 | 0.507 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.112009e-01 | 0.507 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.112009e-01 | 0.507 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.112009e-01 | 0.507 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 3.744440e-01 | 0.427 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.744440e-01 | 0.427 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.744440e-01 | 0.427 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.744440e-01 | 0.427 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.744440e-01 | 0.427 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.744440e-01 | 0.427 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.744440e-01 | 0.427 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.744440e-01 | 0.427 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.520566e-01 | 0.818 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.714626e-01 | 0.766 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.657878e-01 | 0.780 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.657878e-01 | 0.780 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.941131e-01 | 0.531 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.941131e-01 | 0.531 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.941131e-01 | 0.531 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.600040e-01 | 0.796 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.420243e-01 | 0.616 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.464836e-01 | 0.460 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.464836e-01 | 0.460 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.464836e-01 | 0.460 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.464836e-01 | 0.460 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.731236e-01 | 0.762 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.634671e-01 | 0.579 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.634671e-01 | 0.579 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.198407e-01 | 0.377 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.198407e-01 | 0.377 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.198407e-01 | 0.377 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.198407e-01 | 0.377 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.198407e-01 | 0.377 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.552754e-01 | 0.593 | 1 | 1 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.523225e-01 | 0.453 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.790180e-01 | 0.747 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.477857e-01 | 0.606 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 3.536578e-01 | 0.451 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.536578e-01 | 0.451 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.536578e-01 | 0.451 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.815220e-01 | 0.418 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.815220e-01 | 0.418 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.162439e-01 | 0.381 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.106700e-01 | 0.508 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.776950e-01 | 0.556 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.776950e-01 | 0.556 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.776950e-01 | 0.556 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.776950e-01 | 0.556 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.776950e-01 | 0.556 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.758251e-01 | 0.425 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.502480e-01 | 0.347 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.502480e-01 | 0.347 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 4.502480e-01 | 0.347 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.264823e-01 | 0.486 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.603328e-01 | 0.443 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.824232e-01 | 0.417 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.070787e-01 | 0.390 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.734696e-01 | 0.428 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.265176e-01 | 0.370 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.188631e-01 | 0.378 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.052334e-01 | 0.392 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.824886e-01 | 0.417 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.345424e-01 | 0.476 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.179737e-01 | 0.379 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.551141e-01 | 0.450 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.442960e-01 | 0.352 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.375298e-01 | 0.624 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.244087e-01 | 0.489 | 1 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.122140e-01 | 0.673 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.918972e-01 | 0.535 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.135402e-01 | 0.671 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.721025e-01 | 0.429 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.536954e-01 | 0.596 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.282856e-01 | 0.484 | 1 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.282856e-01 | 0.484 | 1 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.913316e-01 | 0.536 | 1 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.413007e-01 | 0.617 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.585536e-01 | 0.800 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.140164e-01 | 0.383 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.871496e-01 | 0.728 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.076470e-01 | 0.512 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.455137e-01 | 0.610 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.373720e-01 | 0.625 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.731236e-01 | 0.762 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.731236e-01 | 0.762 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.771001e-01 | 0.557 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.639574e-01 | 0.785 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.585536e-01 | 0.800 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.413007e-01 | 0.617 | 1 | 1 |
| Frs2-mediated activation | R-HSA-170968 | 3.815831e-01 | 0.418 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.876272e-01 | 0.412 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.413007e-01 | 0.617 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.413007e-01 | 0.617 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.373720e-01 | 0.625 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.198407e-01 | 0.377 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.198407e-01 | 0.377 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.076470e-01 | 0.512 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.106700e-01 | 0.508 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.987204e-01 | 0.399 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.215684e-01 | 0.375 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.962746e-01 | 0.402 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.488785e-01 | 0.457 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.636098e-01 | 0.579 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.654619e-01 | 0.576 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.105684e-01 | 0.387 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.146606e-01 | 0.382 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.801900e-01 | 0.744 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.801900e-01 | 0.744 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.073861e-01 | 0.683 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.799808e-01 | 0.553 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.413007e-01 | 0.617 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.842826e-01 | 0.735 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.781478e-01 | 0.556 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.734150e-01 | 0.563 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.918972e-01 | 0.535 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.536578e-01 | 0.451 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.105684e-01 | 0.387 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.393181e-01 | 0.357 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.442960e-01 | 0.352 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.128081e-01 | 0.384 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.202282e-01 | 0.657 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.749615e-01 | 0.757 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.066333e-01 | 0.685 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.654619e-01 | 0.576 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.654619e-01 | 0.576 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.731236e-01 | 0.762 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.781478e-01 | 0.556 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.008799e-01 | 0.697 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.930252e-01 | 0.533 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.813525e-01 | 0.741 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.813525e-01 | 0.741 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.529597e-01 | 0.452 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.071635e-01 | 0.513 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.265176e-01 | 0.370 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.118044e-01 | 0.385 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.290113e-01 | 0.368 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.953472e-01 | 0.530 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.526118e-01 | 0.453 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.600040e-01 | 0.796 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.499729e-01 | 0.602 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.297439e-01 | 0.367 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.744244e-01 | 0.427 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.413007e-01 | 0.617 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.302055e-01 | 0.481 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.903635e-01 | 0.720 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.618005e-01 | 0.582 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.191160e-01 | 0.496 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.618005e-01 | 0.582 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.618005e-01 | 0.582 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.464836e-01 | 0.460 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.088161e-01 | 0.680 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.261410e-01 | 0.646 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.644623e-01 | 0.784 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.433381e-01 | 0.464 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.070787e-01 | 0.390 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.281556e-01 | 0.642 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 2.294979e-01 | 0.639 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.202282e-01 | 0.657 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.231286e-01 | 0.491 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.523225e-01 | 0.453 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.282528e-01 | 0.484 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.529597e-01 | 0.452 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.791411e-01 | 0.421 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.442960e-01 | 0.352 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.458979e-01 | 0.351 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.476782e-01 | 0.349 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.930486e-01 | 0.533 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.434525e-01 | 0.614 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.420243e-01 | 0.616 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.577604e-01 | 0.589 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.776652e-01 | 0.750 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.654619e-01 | 0.576 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.680329e-01 | 0.434 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.055165e-01 | 0.392 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.502480e-01 | 0.347 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.311922e-01 | 0.480 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.639574e-01 | 0.785 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.298139e-01 | 0.639 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.231286e-01 | 0.491 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.198407e-01 | 0.377 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.992500e-01 | 0.701 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.502480e-01 | 0.347 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.045929e-01 | 0.393 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.379162e-01 | 0.359 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.523225e-01 | 0.453 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.790662e-01 | 0.747 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.290996e-01 | 0.367 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.320651e-01 | 0.634 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.276596e-01 | 0.485 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.987204e-01 | 0.399 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.034194e-01 | 0.692 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.098753e-01 | 0.509 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.231286e-01 | 0.491 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 4.502480e-01 | 0.347 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.461886e-01 | 0.350 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.373720e-01 | 0.625 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.432887e-01 | 0.353 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.034194e-01 | 0.692 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.370277e-01 | 0.625 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 3.464836e-01 | 0.460 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.076470e-01 | 0.512 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.052098e-01 | 0.515 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.734696e-01 | 0.428 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.559103e-01 | 0.807 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.102255e-01 | 0.677 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.651016e-01 | 0.438 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.294979e-01 | 0.639 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.294979e-01 | 0.639 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 2.294979e-01 | 0.639 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.847704e-01 | 0.733 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.236750e-01 | 0.490 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.320651e-01 | 0.634 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.320651e-01 | 0.634 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.746889e-01 | 0.758 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.073861e-01 | 0.683 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.073861e-01 | 0.683 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.063458e-01 | 0.391 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.063458e-01 | 0.391 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.413007e-01 | 0.617 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.112009e-01 | 0.507 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.112009e-01 | 0.507 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.744440e-01 | 0.427 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.941131e-01 | 0.531 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.464836e-01 | 0.460 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.198407e-01 | 0.377 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.815831e-01 | 0.418 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.959958e-01 | 0.708 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.105684e-01 | 0.387 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.987204e-01 | 0.399 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.987204e-01 | 0.399 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.758251e-01 | 0.425 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.476397e-01 | 0.459 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.424986e-01 | 0.615 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.464836e-01 | 0.460 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.800801e-01 | 0.745 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.876272e-01 | 0.412 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.045929e-01 | 0.393 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.373720e-01 | 0.625 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 2.941131e-01 | 0.531 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.815220e-01 | 0.418 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.034194e-01 | 0.692 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 4.502480e-01 | 0.347 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.305933e-01 | 0.481 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.324134e-01 | 0.634 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.413007e-01 | 0.617 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.276596e-01 | 0.485 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.760290e-01 | 0.559 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.682107e-01 | 0.434 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.112639e-01 | 0.386 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.752972e-01 | 0.756 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.471753e-01 | 0.459 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.413007e-01 | 0.617 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.744440e-01 | 0.427 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.731236e-01 | 0.762 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.815831e-01 | 0.418 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.800801e-01 | 0.745 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.461886e-01 | 0.350 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.069647e-01 | 0.390 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.930578e-01 | 0.406 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.734150e-01 | 0.563 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.393181e-01 | 0.357 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.422233e-01 | 0.616 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.466157e-01 | 0.460 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.751987e-01 | 0.756 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.073861e-01 | 0.683 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.063458e-01 | 0.391 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.760290e-01 | 0.559 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.112009e-01 | 0.507 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.464836e-01 | 0.460 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.523225e-01 | 0.453 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.162439e-01 | 0.381 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.987204e-01 | 0.399 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.393181e-01 | 0.357 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.299109e-01 | 0.367 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.045929e-01 | 0.393 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.730915e-01 | 0.762 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.198407e-01 | 0.377 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.373720e-01 | 0.625 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.198407e-01 | 0.377 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.152622e-01 | 0.667 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.320651e-01 | 0.634 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.073861e-01 | 0.683 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.744440e-01 | 0.427 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.744440e-01 | 0.427 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.800801e-01 | 0.745 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.621653e-01 | 0.441 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.299109e-01 | 0.367 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.608488e-01 | 0.794 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.231286e-01 | 0.491 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.799808e-01 | 0.553 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.744440e-01 | 0.427 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.393181e-01 | 0.357 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.895610e-01 | 0.538 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.523225e-01 | 0.453 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.895610e-01 | 0.538 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.815831e-01 | 0.418 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.162439e-01 | 0.381 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.783790e-01 | 0.422 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.930578e-01 | 0.406 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.516694e-01 | 0.345 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.550002e-01 | 0.342 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.550002e-01 | 0.342 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.550002e-01 | 0.342 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.552131e-01 | 0.342 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.552131e-01 | 0.342 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.557135e-01 | 0.341 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.611274e-01 | 0.336 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.634899e-01 | 0.334 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.634899e-01 | 0.334 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.634899e-01 | 0.334 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.634899e-01 | 0.334 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.634899e-01 | 0.334 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.634899e-01 | 0.334 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.634899e-01 | 0.334 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.634899e-01 | 0.334 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.634899e-01 | 0.334 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.634899e-01 | 0.334 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.634899e-01 | 0.334 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.651758e-01 | 0.332 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.668347e-01 | 0.331 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.676428e-01 | 0.330 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.676428e-01 | 0.330 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.676428e-01 | 0.330 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.676428e-01 | 0.330 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.676428e-01 | 0.330 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.676428e-01 | 0.330 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.684590e-01 | 0.329 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.684590e-01 | 0.329 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.700736e-01 | 0.328 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.768877e-01 | 0.322 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.789155e-01 | 0.320 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.789155e-01 | 0.320 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.789155e-01 | 0.320 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.789155e-01 | 0.320 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 4.789155e-01 | 0.320 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.789155e-01 | 0.320 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.789155e-01 | 0.320 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.789155e-01 | 0.320 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.789155e-01 | 0.320 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.789155e-01 | 0.320 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.789155e-01 | 0.320 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.789155e-01 | 0.320 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.789155e-01 | 0.320 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.797743e-01 | 0.319 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.797743e-01 | 0.319 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.797743e-01 | 0.319 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.801197e-01 | 0.319 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.803314e-01 | 0.318 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.823165e-01 | 0.317 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.823165e-01 | 0.317 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.823165e-01 | 0.317 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.834127e-01 | 0.316 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.834127e-01 | 0.316 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.834127e-01 | 0.316 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 4.834127e-01 | 0.316 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 4.834127e-01 | 0.316 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.834127e-01 | 0.316 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.866212e-01 | 0.313 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.891213e-01 | 0.311 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.938734e-01 | 0.306 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.954296e-01 | 0.305 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.954296e-01 | 0.305 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.954296e-01 | 0.305 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.954296e-01 | 0.305 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.967634e-01 | 0.304 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.041547e-01 | 0.297 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.041547e-01 | 0.297 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.041547e-01 | 0.297 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.041547e-01 | 0.297 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.051408e-01 | 0.297 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.051408e-01 | 0.297 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.051408e-01 | 0.297 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.051408e-01 | 0.297 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.051408e-01 | 0.297 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.051408e-01 | 0.297 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.051408e-01 | 0.297 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.059511e-01 | 0.296 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.059511e-01 | 0.296 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.110973e-01 | 0.291 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.155886e-01 | 0.288 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.155886e-01 | 0.288 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.219911e-01 | 0.282 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.219911e-01 | 0.282 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.225804e-01 | 0.282 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.225804e-01 | 0.282 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.225804e-01 | 0.282 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.280715e-01 | 0.277 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.332921e-01 | 0.273 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.336920e-01 | 0.273 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.343385e-01 | 0.272 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.367887e-01 | 0.270 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.367887e-01 | 0.270 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.392149e-01 | 0.268 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.396161e-01 | 0.268 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.404676e-01 | 0.267 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.426179e-01 | 0.266 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.426179e-01 | 0.266 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.426179e-01 | 0.266 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.426179e-01 | 0.266 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.426179e-01 | 0.266 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.426179e-01 | 0.266 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.426179e-01 | 0.266 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.426179e-01 | 0.266 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.426179e-01 | 0.266 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.426179e-01 | 0.266 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.426179e-01 | 0.266 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.426179e-01 | 0.266 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.426179e-01 | 0.266 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.426179e-01 | 0.266 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.438431e-01 | 0.265 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.438431e-01 | 0.265 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.446296e-01 | 0.264 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.446296e-01 | 0.264 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.446296e-01 | 0.264 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.446296e-01 | 0.264 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.446296e-01 | 0.264 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 5.446296e-01 | 0.264 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 5.466565e-01 | 0.262 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.466565e-01 | 0.262 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.466565e-01 | 0.262 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 5.490118e-01 | 0.260 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.498024e-01 | 0.260 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.511236e-01 | 0.259 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.563145e-01 | 0.255 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.578502e-01 | 0.253 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.653024e-01 | 0.248 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.673936e-01 | 0.246 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.742755e-01 | 0.241 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.742755e-01 | 0.241 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.742755e-01 | 0.241 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.746538e-01 | 0.241 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.746580e-01 | 0.241 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.746580e-01 | 0.241 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.746580e-01 | 0.241 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.746580e-01 | 0.241 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.754685e-01 | 0.240 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.765245e-01 | 0.239 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.765245e-01 | 0.239 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.765245e-01 | 0.239 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.765346e-01 | 0.239 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.818626e-01 | 0.235 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.818626e-01 | 0.235 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.818626e-01 | 0.235 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.818626e-01 | 0.235 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.848060e-01 | 0.233 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.940702e-01 | 0.226 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.940702e-01 | 0.226 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.940702e-01 | 0.226 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.942196e-01 | 0.226 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.942861e-01 | 0.226 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.947561e-01 | 0.226 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.949141e-01 | 0.226 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.963098e-01 | 0.225 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.964631e-01 | 0.224 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.964631e-01 | 0.224 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.980254e-01 | 0.223 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.985359e-01 | 0.223 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.985359e-01 | 0.223 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.985359e-01 | 0.223 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.985359e-01 | 0.223 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.985359e-01 | 0.223 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.985359e-01 | 0.223 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.985359e-01 | 0.223 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.985359e-01 | 0.223 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.985359e-01 | 0.223 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.985359e-01 | 0.223 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.985359e-01 | 0.223 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.985359e-01 | 0.223 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.985359e-01 | 0.223 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.985359e-01 | 0.223 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.994498e-01 | 0.222 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 5.994498e-01 | 0.222 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.051253e-01 | 0.218 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.051253e-01 | 0.218 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.051253e-01 | 0.218 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.051253e-01 | 0.218 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.051253e-01 | 0.218 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.051253e-01 | 0.218 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.051253e-01 | 0.218 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.051253e-01 | 0.218 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.082715e-01 | 0.216 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.110569e-01 | 0.214 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.112415e-01 | 0.214 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.128174e-01 | 0.213 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.146466e-01 | 0.211 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.168011e-01 | 0.210 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.168011e-01 | 0.210 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.168011e-01 | 0.210 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.168011e-01 | 0.210 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 6.168011e-01 | 0.210 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.168011e-01 | 0.210 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.168011e-01 | 0.210 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.168011e-01 | 0.210 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.179876e-01 | 0.209 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.179876e-01 | 0.209 | 1 | 1 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.179876e-01 | 0.209 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.179876e-01 | 0.209 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.233550e-01 | 0.205 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.233550e-01 | 0.205 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.233550e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.233550e-01 | 0.205 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.233550e-01 | 0.205 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.233550e-01 | 0.205 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.252521e-01 | 0.204 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.304070e-01 | 0.200 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.324134e-01 | 0.199 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.324134e-01 | 0.199 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.324134e-01 | 0.199 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.324134e-01 | 0.199 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.324134e-01 | 0.199 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.338281e-01 | 0.198 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.338281e-01 | 0.198 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.400449e-01 | 0.194 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.419048e-01 | 0.193 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.444109e-01 | 0.191 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.463359e-01 | 0.190 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.476204e-01 | 0.189 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.476204e-01 | 0.189 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.476204e-01 | 0.189 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.476204e-01 | 0.189 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.476204e-01 | 0.189 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.476204e-01 | 0.189 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.476204e-01 | 0.189 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.476204e-01 | 0.189 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.476204e-01 | 0.189 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.476204e-01 | 0.189 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.476204e-01 | 0.189 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.476204e-01 | 0.189 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.476204e-01 | 0.189 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 6.476204e-01 | 0.189 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.476204e-01 | 0.189 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.476204e-01 | 0.189 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.476204e-01 | 0.189 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.476204e-01 | 0.189 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.476204e-01 | 0.189 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.476204e-01 | 0.189 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.494496e-01 | 0.187 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.494496e-01 | 0.187 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.494496e-01 | 0.187 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.494496e-01 | 0.187 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.494496e-01 | 0.187 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.494496e-01 | 0.187 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.494496e-01 | 0.187 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.494496e-01 | 0.187 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.574694e-01 | 0.182 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.583621e-01 | 0.182 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.592437e-01 | 0.181 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.646990e-01 | 0.177 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.646990e-01 | 0.177 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.669265e-01 | 0.176 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.683690e-01 | 0.175 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.683690e-01 | 0.175 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.683690e-01 | 0.175 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.759066e-01 | 0.170 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.798457e-01 | 0.168 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.798457e-01 | 0.168 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 6.798457e-01 | 0.168 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.798457e-01 | 0.168 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.798457e-01 | 0.168 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.798457e-01 | 0.168 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.810933e-01 | 0.167 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.830178e-01 | 0.166 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.868418e-01 | 0.163 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.878609e-01 | 0.162 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.894399e-01 | 0.162 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.907061e-01 | 0.161 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.907061e-01 | 0.161 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.907061e-01 | 0.161 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.907061e-01 | 0.161 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.907061e-01 | 0.161 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.907061e-01 | 0.161 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.907061e-01 | 0.161 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.907061e-01 | 0.161 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.907061e-01 | 0.161 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.907061e-01 | 0.161 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.907061e-01 | 0.161 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.907061e-01 | 0.161 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.907061e-01 | 0.161 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.907061e-01 | 0.161 | 0 | 0 |
| Metabolism of vitamin K | R-HSA-6806664 | 6.907061e-01 | 0.161 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.907061e-01 | 0.161 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.909950e-01 | 0.161 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.909950e-01 | 0.161 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.958966e-01 | 0.157 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.962259e-01 | 0.157 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.969268e-01 | 0.157 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.969268e-01 | 0.157 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.969706e-01 | 0.157 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.972633e-01 | 0.157 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.986575e-01 | 0.156 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.997239e-01 | 0.155 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.002640e-01 | 0.155 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.002640e-01 | 0.155 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.046537e-01 | 0.152 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.062139e-01 | 0.151 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.062139e-01 | 0.151 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.062139e-01 | 0.151 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.062139e-01 | 0.151 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.062139e-01 | 0.151 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.080521e-01 | 0.150 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.080521e-01 | 0.150 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.080521e-01 | 0.150 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.080521e-01 | 0.150 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.080521e-01 | 0.150 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.080521e-01 | 0.150 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.080521e-01 | 0.150 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.080521e-01 | 0.150 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.095427e-01 | 0.149 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.147938e-01 | 0.146 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.156622e-01 | 0.145 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.193682e-01 | 0.143 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.198095e-01 | 0.143 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.198095e-01 | 0.143 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.208227e-01 | 0.142 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.208227e-01 | 0.142 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.208235e-01 | 0.142 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.213501e-01 | 0.142 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.217078e-01 | 0.142 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.277322e-01 | 0.138 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.281360e-01 | 0.138 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.281360e-01 | 0.138 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.281360e-01 | 0.138 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.281360e-01 | 0.138 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 7.285259e-01 | 0.138 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.285259e-01 | 0.138 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.285259e-01 | 0.138 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.285259e-01 | 0.138 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 7.285259e-01 | 0.138 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.285259e-01 | 0.138 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.285259e-01 | 0.138 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.285259e-01 | 0.138 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.285259e-01 | 0.138 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.285259e-01 | 0.138 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.285259e-01 | 0.138 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.285259e-01 | 0.138 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 7.285259e-01 | 0.138 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.285259e-01 | 0.138 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.285259e-01 | 0.138 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.285259e-01 | 0.138 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.286785e-01 | 0.137 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.309470e-01 | 0.136 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.319013e-01 | 0.136 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.319013e-01 | 0.136 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.335244e-01 | 0.135 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.335244e-01 | 0.135 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.341498e-01 | 0.134 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.341498e-01 | 0.134 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.341498e-01 | 0.134 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.341498e-01 | 0.134 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.341498e-01 | 0.134 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.341498e-01 | 0.134 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.414321e-01 | 0.130 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.431580e-01 | 0.129 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.468547e-01 | 0.127 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.468547e-01 | 0.127 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.487525e-01 | 0.126 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.487525e-01 | 0.126 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.487525e-01 | 0.126 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.492627e-01 | 0.125 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.537713e-01 | 0.123 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.582325e-01 | 0.120 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.582325e-01 | 0.120 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.582325e-01 | 0.120 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.582325e-01 | 0.120 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.582325e-01 | 0.120 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.582325e-01 | 0.120 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.617232e-01 | 0.118 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.617232e-01 | 0.118 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.617232e-01 | 0.118 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.617232e-01 | 0.118 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.617232e-01 | 0.118 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.617232e-01 | 0.118 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.617232e-01 | 0.118 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.617232e-01 | 0.118 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.617232e-01 | 0.118 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.617232e-01 | 0.118 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.617232e-01 | 0.118 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.617232e-01 | 0.118 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.617232e-01 | 0.118 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.617232e-01 | 0.118 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.617232e-01 | 0.118 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.617232e-01 | 0.118 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.640845e-01 | 0.117 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.640845e-01 | 0.117 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.640845e-01 | 0.117 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.655776e-01 | 0.116 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.677387e-01 | 0.115 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.680963e-01 | 0.115 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.680963e-01 | 0.115 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.680963e-01 | 0.115 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.680963e-01 | 0.115 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.683567e-01 | 0.114 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.684058e-01 | 0.114 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.736667e-01 | 0.111 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.764736e-01 | 0.110 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.786242e-01 | 0.109 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.787042e-01 | 0.109 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.792527e-01 | 0.108 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.804028e-01 | 0.108 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.804028e-01 | 0.108 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.804028e-01 | 0.108 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.804028e-01 | 0.108 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.831061e-01 | 0.106 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.862070e-01 | 0.104 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.907941e-01 | 0.102 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.908626e-01 | 0.102 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.908626e-01 | 0.102 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 7.908626e-01 | 0.102 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.908626e-01 | 0.102 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.908626e-01 | 0.102 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.908626e-01 | 0.102 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.908626e-01 | 0.102 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.908626e-01 | 0.102 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.908626e-01 | 0.102 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.908626e-01 | 0.102 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.908626e-01 | 0.102 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.908626e-01 | 0.102 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.908626e-01 | 0.102 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.923168e-01 | 0.101 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.932621e-01 | 0.101 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.951201e-01 | 0.100 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.957798e-01 | 0.099 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.957798e-01 | 0.099 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.965671e-01 | 0.099 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.965671e-01 | 0.099 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.007682e-01 | 0.096 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.007682e-01 | 0.096 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.007682e-01 | 0.096 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.007682e-01 | 0.096 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.007682e-01 | 0.096 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.047797e-01 | 0.094 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.049100e-01 | 0.094 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.062375e-01 | 0.094 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.062375e-01 | 0.094 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.062375e-01 | 0.094 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.102920e-01 | 0.091 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.102920e-01 | 0.091 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.102920e-01 | 0.091 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.126524e-01 | 0.090 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.164399e-01 | 0.088 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.164399e-01 | 0.088 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.164399e-01 | 0.088 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.164399e-01 | 0.088 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.164399e-01 | 0.088 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.164399e-01 | 0.088 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.164399e-01 | 0.088 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.164399e-01 | 0.088 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.164399e-01 | 0.088 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.164399e-01 | 0.088 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.165492e-01 | 0.088 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.184717e-01 | 0.087 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.184717e-01 | 0.087 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.189096e-01 | 0.087 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.189096e-01 | 0.087 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.189096e-01 | 0.087 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.189475e-01 | 0.087 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.189475e-01 | 0.087 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.189475e-01 | 0.087 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.189475e-01 | 0.087 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.194385e-01 | 0.086 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.194385e-01 | 0.086 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.194385e-01 | 0.086 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.194385e-01 | 0.086 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.216827e-01 | 0.085 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.239500e-01 | 0.084 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.245675e-01 | 0.084 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.286045e-01 | 0.082 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.309774e-01 | 0.080 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.309774e-01 | 0.080 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.309774e-01 | 0.080 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.309774e-01 | 0.080 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.336002e-01 | 0.079 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.365236e-01 | 0.078 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.365236e-01 | 0.078 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.368091e-01 | 0.077 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.388905e-01 | 0.076 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.388905e-01 | 0.076 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.388905e-01 | 0.076 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.388905e-01 | 0.076 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.388905e-01 | 0.076 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.388905e-01 | 0.076 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.388905e-01 | 0.076 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.388905e-01 | 0.076 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.388905e-01 | 0.076 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.388905e-01 | 0.076 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.388905e-01 | 0.076 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.388905e-01 | 0.076 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.388905e-01 | 0.076 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.388905e-01 | 0.076 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.443923e-01 | 0.073 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.486801e-01 | 0.071 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.488241e-01 | 0.071 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.521319e-01 | 0.069 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.521319e-01 | 0.069 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.521319e-01 | 0.069 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.521319e-01 | 0.069 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.521319e-01 | 0.069 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.521319e-01 | 0.069 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.521319e-01 | 0.069 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 8.521319e-01 | 0.069 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.536546e-01 | 0.069 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.557050e-01 | 0.068 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.585964e-01 | 0.066 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 8.585964e-01 | 0.066 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.585964e-01 | 0.066 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.585964e-01 | 0.066 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.585964e-01 | 0.066 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.585964e-01 | 0.066 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.585964e-01 | 0.066 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.585964e-01 | 0.066 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.585964e-01 | 0.066 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.585964e-01 | 0.066 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.585964e-01 | 0.066 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.599200e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.601041e-01 | 0.065 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.613318e-01 | 0.065 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.663689e-01 | 0.062 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.663689e-01 | 0.062 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.663689e-01 | 0.062 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.692508e-01 | 0.061 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.697616e-01 | 0.061 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.697616e-01 | 0.061 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.722738e-01 | 0.059 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.727218e-01 | 0.059 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.727641e-01 | 0.059 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.758930e-01 | 0.058 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.758930e-01 | 0.058 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.758930e-01 | 0.058 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.758930e-01 | 0.058 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.758930e-01 | 0.058 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.758930e-01 | 0.058 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.758930e-01 | 0.058 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.758930e-01 | 0.058 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.758930e-01 | 0.058 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.758930e-01 | 0.058 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.758930e-01 | 0.058 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.763042e-01 | 0.057 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.780650e-01 | 0.056 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.793366e-01 | 0.056 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.793366e-01 | 0.056 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.793366e-01 | 0.056 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.805164e-01 | 0.055 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.805164e-01 | 0.055 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.805164e-01 | 0.055 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.805164e-01 | 0.055 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.806478e-01 | 0.055 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.806478e-01 | 0.055 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.816782e-01 | 0.055 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.819226e-01 | 0.055 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.881200e-01 | 0.052 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 8.881200e-01 | 0.052 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.897160e-01 | 0.051 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.897160e-01 | 0.051 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.910747e-01 | 0.050 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.910747e-01 | 0.050 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.910747e-01 | 0.050 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.910747e-01 | 0.050 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.910747e-01 | 0.050 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.910747e-01 | 0.050 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.910747e-01 | 0.050 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.910747e-01 | 0.050 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.910747e-01 | 0.050 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.910747e-01 | 0.050 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.910747e-01 | 0.050 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.911324e-01 | 0.050 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.911324e-01 | 0.050 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.911324e-01 | 0.050 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.925436e-01 | 0.049 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.955056e-01 | 0.048 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.979817e-01 | 0.047 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.982894e-01 | 0.047 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.017986e-01 | 0.045 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.018489e-01 | 0.045 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.018489e-01 | 0.045 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.018879e-01 | 0.045 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.044001e-01 | 0.044 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.044001e-01 | 0.044 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.044001e-01 | 0.044 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.044001e-01 | 0.044 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.044001e-01 | 0.044 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 9.044001e-01 | 0.044 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.044001e-01 | 0.044 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.044001e-01 | 0.044 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.049140e-01 | 0.043 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.053771e-01 | 0.043 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.062718e-01 | 0.043 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.082132e-01 | 0.042 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.082550e-01 | 0.042 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.082550e-01 | 0.042 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.085263e-01 | 0.042 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.103275e-01 | 0.041 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.103624e-01 | 0.041 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.111133e-01 | 0.040 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.115736e-01 | 0.040 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.115736e-01 | 0.040 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.115736e-01 | 0.040 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.115736e-01 | 0.040 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.115736e-01 | 0.040 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.115736e-01 | 0.040 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.115736e-01 | 0.040 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.115736e-01 | 0.040 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.123000e-01 | 0.040 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.136897e-01 | 0.039 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.160960e-01 | 0.038 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.160960e-01 | 0.038 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.160960e-01 | 0.038 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.160960e-01 | 0.038 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.160960e-01 | 0.038 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 9.160960e-01 | 0.038 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.173062e-01 | 0.037 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.173062e-01 | 0.037 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.181782e-01 | 0.037 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.187499e-01 | 0.037 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.203887e-01 | 0.036 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.203887e-01 | 0.036 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.203887e-01 | 0.036 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.205809e-01 | 0.036 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.231190e-01 | 0.035 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.244262e-01 | 0.034 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.253964e-01 | 0.034 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.255683e-01 | 0.034 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.263615e-01 | 0.033 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.263615e-01 | 0.033 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.263615e-01 | 0.033 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.263615e-01 | 0.033 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.263615e-01 | 0.033 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.263615e-01 | 0.033 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.283711e-01 | 0.032 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.283711e-01 | 0.032 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.283870e-01 | 0.032 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.297511e-01 | 0.032 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.304668e-01 | 0.031 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.320261e-01 | 0.031 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.327800e-01 | 0.030 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.329001e-01 | 0.030 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.353717e-01 | 0.029 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.353717e-01 | 0.029 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.353717e-01 | 0.029 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.353717e-01 | 0.029 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.353717e-01 | 0.029 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.353717e-01 | 0.029 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 9.353717e-01 | 0.029 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.353717e-01 | 0.029 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.353717e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.355926e-01 | 0.029 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.355926e-01 | 0.029 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.355926e-01 | 0.029 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.355926e-01 | 0.029 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.356492e-01 | 0.029 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.357301e-01 | 0.029 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.357301e-01 | 0.029 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.381090e-01 | 0.028 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.394155e-01 | 0.027 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.406334e-01 | 0.027 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.421199e-01 | 0.026 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.422400e-01 | 0.026 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.432798e-01 | 0.025 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.432798e-01 | 0.025 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.432798e-01 | 0.025 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.432798e-01 | 0.025 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.434620e-01 | 0.025 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.436848e-01 | 0.025 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.445835e-01 | 0.025 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.451971e-01 | 0.024 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.457436e-01 | 0.024 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.471312e-01 | 0.024 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.480146e-01 | 0.023 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.480146e-01 | 0.023 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.481526e-01 | 0.023 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.487910e-01 | 0.023 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.487910e-01 | 0.023 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.494411e-01 | 0.023 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.502207e-01 | 0.022 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.502207e-01 | 0.022 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.502207e-01 | 0.022 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.502207e-01 | 0.022 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.503879e-01 | 0.022 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.533339e-01 | 0.021 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.533339e-01 | 0.021 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.533339e-01 | 0.021 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.534630e-01 | 0.021 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.534630e-01 | 0.021 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.534630e-01 | 0.021 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.545245e-01 | 0.020 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.563126e-01 | 0.019 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.563126e-01 | 0.019 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.563126e-01 | 0.019 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.564796e-01 | 0.019 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.570457e-01 | 0.019 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.581302e-01 | 0.019 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.581302e-01 | 0.019 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.581302e-01 | 0.019 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.606045e-01 | 0.017 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.616352e-01 | 0.017 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.616352e-01 | 0.017 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.616592e-01 | 0.017 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.616592e-01 | 0.017 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.616592e-01 | 0.017 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.616592e-01 | 0.017 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.616592e-01 | 0.017 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.616592e-01 | 0.017 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.624519e-01 | 0.017 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.645705e-01 | 0.016 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.651958e-01 | 0.015 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.651958e-01 | 0.015 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.651958e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.663432e-01 | 0.015 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.663432e-01 | 0.015 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.663432e-01 | 0.015 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.663518e-01 | 0.015 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.663518e-01 | 0.015 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.663518e-01 | 0.015 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.663518e-01 | 0.015 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.666784e-01 | 0.015 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.678629e-01 | 0.014 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.684431e-01 | 0.014 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.684431e-01 | 0.014 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.687286e-01 | 0.014 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.698448e-01 | 0.013 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.698448e-01 | 0.013 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.698448e-01 | 0.013 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.698448e-01 | 0.013 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.698448e-01 | 0.013 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.698448e-01 | 0.013 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.704703e-01 | 0.013 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.704703e-01 | 0.013 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.704703e-01 | 0.013 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.704703e-01 | 0.013 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.704703e-01 | 0.013 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.704703e-01 | 0.013 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.704703e-01 | 0.013 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.721892e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.729937e-01 | 0.012 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.729937e-01 | 0.012 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.729937e-01 | 0.012 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.729937e-01 | 0.012 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.729937e-01 | 0.012 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.740850e-01 | 0.011 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.740850e-01 | 0.011 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.740850e-01 | 0.011 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.740850e-01 | 0.011 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.740850e-01 | 0.011 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.746129e-01 | 0.011 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.747400e-01 | 0.011 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.749604e-01 | 0.011 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.758237e-01 | 0.011 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.758237e-01 | 0.011 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.768371e-01 | 0.010 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.772573e-01 | 0.010 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.772573e-01 | 0.010 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.772573e-01 | 0.010 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.772573e-01 | 0.010 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.772573e-01 | 0.010 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.773141e-01 | 0.010 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.783658e-01 | 0.009 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.783658e-01 | 0.009 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.783658e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.800415e-01 | 0.009 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.800415e-01 | 0.009 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.806481e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.806481e-01 | 0.008 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.810997e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.816565e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.816951e-01 | 0.008 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.824849e-01 | 0.008 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.824849e-01 | 0.008 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.824849e-01 | 0.008 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.824849e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.826959e-01 | 0.008 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.826959e-01 | 0.008 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.843418e-01 | 0.007 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.845325e-01 | 0.007 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.845325e-01 | 0.007 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.846294e-01 | 0.007 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.846294e-01 | 0.007 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.846294e-01 | 0.007 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.848407e-01 | 0.007 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.855426e-01 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.858668e-01 | 0.006 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.861790e-01 | 0.006 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.861790e-01 | 0.006 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.861790e-01 | 0.006 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.862899e-01 | 0.006 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.865114e-01 | 0.006 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.865114e-01 | 0.006 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.865114e-01 | 0.006 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.865114e-01 | 0.006 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.865114e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.865114e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.870685e-01 | 0.006 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.876542e-01 | 0.005 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.876542e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.876542e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.877732e-01 | 0.005 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.881631e-01 | 0.005 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.881631e-01 | 0.005 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.881631e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.884601e-01 | 0.005 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.888516e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.889755e-01 | 0.005 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.889912e-01 | 0.005 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.890640e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.890640e-01 | 0.005 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.895366e-01 | 0.005 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.895892e-01 | 0.005 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.896126e-01 | 0.005 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.901197e-01 | 0.004 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.901585e-01 | 0.004 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.902493e-01 | 0.004 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.906114e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.913076e-01 | 0.004 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.918049e-01 | 0.004 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.918242e-01 | 0.004 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.920010e-01 | 0.003 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.920010e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.921641e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.923731e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.926919e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.929662e-01 | 0.003 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.929662e-01 | 0.003 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.929807e-01 | 0.003 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.930110e-01 | 0.003 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.931294e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.934614e-01 | 0.003 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.938130e-01 | 0.003 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.938405e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.942943e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.944445e-01 | 0.002 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.945950e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.948001e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.948547e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.950588e-01 | 0.002 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.950588e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.952571e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.952571e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.952571e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.952571e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.956858e-01 | 0.002 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.958479e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.958748e-01 | 0.002 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.960703e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.963480e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.963480e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.963480e-01 | 0.002 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.965003e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.967954e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.967954e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.970328e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.970328e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.970426e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.971881e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.973112e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.975150e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.975326e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.978350e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.978350e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.978350e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.979831e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.980990e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.981003e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.981548e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.983331e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.983613e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.986184e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.986257e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.986257e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.987677e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.987763e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.987783e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.987783e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.987933e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.987973e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.988740e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.988740e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.988946e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.990048e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.990120e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.990159e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.991427e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.992394e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.992943e-01 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.993327e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.993993e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.994145e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.994145e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.994266e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.994847e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.994863e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.995493e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.995493e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.995493e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.995797e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.996269e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.996531e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.997062e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.997329e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.997510e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.997689e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997711e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.997944e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997951e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998116e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.998333e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998388e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.998418e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.998480e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998651e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.998705e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.998935e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999050e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999063e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999243e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999270e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999357e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999445e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999445e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999614e-01 | 0.000 | 1 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999666e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999671e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999712e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999731e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999747e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999747e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999752e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999778e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999790e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999809e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999846e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999874e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999885e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999888e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999905e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999906e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999911e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999913e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999943e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999945e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999958e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999960e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999963e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999975e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999975e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999980e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999982e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999987e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999989e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.241363e-13 | 12.281 | 1 | 1 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.340595e-12 | 11.198 | 1 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.790102e-11 | 10.056 | 1 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.790102e-11 | 10.056 | 1 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.442225e-11 | 10.025 | 1 | 1 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.147372e-11 | 10.146 | 1 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.392698e-10 | 9.856 | 1 | 1 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.372652e-10 | 9.862 | 1 | 1 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.738760e-10 | 9.760 | 1 | 1 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.017749e-10 | 9.695 | 1 | 1 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.729874e-10 | 9.172 | 1 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.808748e-10 | 9.167 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 1.179056e-09 | 8.928 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.352953e-09 | 8.869 | 1 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.760829e-09 | 8.754 | 1 | 1 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.871928e-09 | 8.231 | 1 | 1 |
| Homology Directed Repair | R-HSA-5693538 | 5.685629e-09 | 8.245 | 1 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.204767e-09 | 8.284 | 1 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.028571e-08 | 7.988 | 1 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.028571e-08 | 7.988 | 1 | 1 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.028571e-08 | 7.988 | 1 | 1 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.028571e-08 | 7.988 | 1 | 1 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.328039e-08 | 7.478 | 1 | 1 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.378906e-08 | 7.359 | 1 | 1 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.905057e-08 | 7.309 | 1 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.207246e-07 | 6.918 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.349441e-07 | 6.870 | 1 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.845221e-07 | 6.734 | 1 | 1 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.027768e-07 | 6.693 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.244126e-07 | 6.649 | 1 | 1 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.993965e-07 | 6.399 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.903376e-07 | 6.102 | 1 | 0 |
| Heme signaling | R-HSA-9707616 | 1.276116e-06 | 5.894 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.810688e-06 | 5.742 | 1 | 1 |
| Generic Transcription Pathway | R-HSA-212436 | 1.410451e-05 | 4.851 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.371462e-05 | 4.472 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.453772e-05 | 4.462 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.667094e-05 | 4.176 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.276448e-04 | 3.894 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.427715e-04 | 3.845 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.779547e-04 | 3.750 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.126735e-04 | 3.672 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.892132e-04 | 3.539 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.199333e-04 | 3.495 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.431025e-04 | 3.465 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.345055e-04 | 3.476 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.662994e-04 | 3.436 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.034096e-04 | 3.394 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.566627e-04 | 3.340 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.633567e-04 | 3.334 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.595050e-04 | 3.252 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.383767e-04 | 3.195 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.434072e-04 | 3.192 | 1 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.907936e-04 | 3.102 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.037233e-04 | 3.044 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.093298e-03 | 2.961 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.262059e-03 | 2.899 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.545771e-03 | 2.811 | 1 | 1 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.564787e-03 | 2.806 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.652162e-03 | 2.782 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.753387e-03 | 2.756 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.764366e-03 | 2.753 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.959228e-03 | 2.708 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.951493e-03 | 2.710 | 1 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.991462e-03 | 2.701 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.189784e-03 | 2.660 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.533776e-03 | 2.596 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.695742e-03 | 2.569 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.614708e-03 | 2.583 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.841556e-03 | 2.546 | 1 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.047357e-03 | 2.516 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.604774e-03 | 2.443 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.604774e-03 | 2.443 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.442087e-03 | 2.463 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.593595e-03 | 2.444 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.530364e-03 | 2.452 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.331214e-03 | 2.477 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.617445e-03 | 2.442 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.617445e-03 | 2.442 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.661745e-03 | 2.436 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.007134e-03 | 2.397 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.806786e-03 | 2.419 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.021369e-03 | 2.396 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.140892e-03 | 2.383 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.387227e-03 | 2.358 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.387227e-03 | 2.358 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.387227e-03 | 2.358 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.387227e-03 | 2.358 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.387227e-03 | 2.358 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.554310e-03 | 2.342 | 1 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.455310e-03 | 2.351 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.231478e-03 | 2.374 | 1 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.669435e-03 | 2.331 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.800081e-03 | 2.319 | 1 | 1 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.857335e-03 | 2.232 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.857335e-03 | 2.232 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.760244e-03 | 2.240 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.857335e-03 | 2.232 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.040274e-03 | 2.219 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.402429e-03 | 2.194 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.402429e-03 | 2.194 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.543050e-03 | 2.184 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.497635e-03 | 2.187 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.865580e-03 | 2.163 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.865580e-03 | 2.163 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.031600e-03 | 2.153 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.085101e-03 | 2.150 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.456544e-03 | 2.127 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.705655e-03 | 2.113 | 1 | 1 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.611427e-03 | 2.119 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.654724e-03 | 2.116 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.772980e-03 | 2.109 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.901259e-03 | 2.102 | 1 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.000552e-03 | 2.097 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.000552e-03 | 2.097 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.045059e-03 | 2.094 | 1 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.119366e-03 | 2.090 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 9.091287e-03 | 2.041 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.101734e-03 | 2.041 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.853411e-03 | 2.006 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.157291e-03 | 2.038 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.934855e-03 | 2.003 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.013760e-02 | 1.994 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.038092e-02 | 1.984 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.067219e-02 | 1.972 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.126659e-02 | 1.948 | 1 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.109618e-02 | 1.955 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.137678e-02 | 1.944 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.067219e-02 | 1.972 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.155647e-02 | 1.937 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.184175e-02 | 1.927 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.290954e-02 | 1.889 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.441005e-02 | 1.841 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.347667e-02 | 1.870 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.322461e-02 | 1.879 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.418509e-02 | 1.848 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.418509e-02 | 1.848 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.424370e-02 | 1.846 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.499516e-02 | 1.824 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.754954e-02 | 1.756 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.754954e-02 | 1.756 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.754954e-02 | 1.756 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.754954e-02 | 1.756 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.754954e-02 | 1.756 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.754954e-02 | 1.756 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.754954e-02 | 1.756 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.754954e-02 | 1.756 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.754954e-02 | 1.756 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.717003e-02 | 1.765 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.717003e-02 | 1.765 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.596159e-02 | 1.797 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.596159e-02 | 1.797 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.611070e-02 | 1.793 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.611070e-02 | 1.793 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.611070e-02 | 1.793 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.697399e-02 | 1.770 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.717003e-02 | 1.765 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.758278e-02 | 1.755 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.859565e-02 | 1.731 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.859565e-02 | 1.731 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.889870e-02 | 1.724 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.901481e-02 | 1.721 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.901481e-02 | 1.721 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.931350e-02 | 1.714 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.950372e-02 | 1.710 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.950372e-02 | 1.710 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 1.976739e-02 | 1.704 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.994791e-02 | 1.700 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.094016e-02 | 1.679 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.106230e-02 | 1.676 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.271516e-02 | 1.644 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.280626e-02 | 1.642 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.315211e-02 | 1.635 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.315211e-02 | 1.635 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.315211e-02 | 1.635 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.364560e-02 | 1.626 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.370966e-02 | 1.625 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.370966e-02 | 1.625 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.370966e-02 | 1.625 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.370966e-02 | 1.625 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.370966e-02 | 1.625 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.470304e-02 | 1.607 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.492921e-02 | 1.603 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.492921e-02 | 1.603 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.544190e-02 | 1.594 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.965171e-02 | 1.528 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.965171e-02 | 1.528 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.000253e-02 | 1.523 | 1 | 1 |
| PPARA activates gene expression | R-HSA-1989781 | 2.978981e-02 | 1.526 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.965171e-02 | 1.528 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.850589e-02 | 1.545 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.000253e-02 | 1.523 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.766051e-02 | 1.558 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.033678e-02 | 1.518 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.078912e-02 | 1.512 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.151700e-02 | 1.501 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.191512e-02 | 1.496 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 3.346173e-02 | 1.475 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.382070e-02 | 1.471 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.419714e-02 | 1.466 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.419714e-02 | 1.466 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.419714e-02 | 1.466 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.441200e-02 | 1.463 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.645515e-02 | 1.438 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.699223e-02 | 1.432 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.699223e-02 | 1.432 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.699223e-02 | 1.432 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.711614e-02 | 1.430 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.414369e-02 | 1.355 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.206767e-02 | 1.376 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.883083e-02 | 1.411 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.883083e-02 | 1.411 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.883083e-02 | 1.411 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.465524e-02 | 1.350 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.432334e-02 | 1.353 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.086596e-02 | 1.389 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.316396e-02 | 1.365 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.257425e-02 | 1.371 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.507169e-02 | 1.346 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.414369e-02 | 1.355 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.011919e-02 | 1.397 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.750121e-02 | 1.323 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.750121e-02 | 1.323 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.750121e-02 | 1.323 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 4.750121e-02 | 1.323 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.873824e-02 | 1.312 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.873824e-02 | 1.312 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.101300e-02 | 1.292 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.101300e-02 | 1.292 | 1 | 1 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.101300e-02 | 1.292 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.109666e-02 | 1.292 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.109666e-02 | 1.292 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.164521e-02 | 1.210 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 6.164521e-02 | 1.210 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.164521e-02 | 1.210 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.164521e-02 | 1.210 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.164521e-02 | 1.210 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.164521e-02 | 1.210 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.381353e-02 | 1.269 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.273147e-02 | 1.278 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.735266e-02 | 1.241 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.735266e-02 | 1.241 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.757202e-02 | 1.240 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.328999e-02 | 1.273 | 1 | 1 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.273147e-02 | 1.278 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.680575e-02 | 1.246 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.101633e-02 | 1.215 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.101633e-02 | 1.215 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.138914e-02 | 1.212 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.624968e-02 | 1.250 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.572202e-02 | 1.254 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.285250e-02 | 1.202 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.482740e-02 | 1.188 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.572375e-02 | 1.182 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.575358e-02 | 1.182 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.575358e-02 | 1.182 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.575358e-02 | 1.182 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.575358e-02 | 1.182 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.575358e-02 | 1.182 | 1 | 1 |
| ESR-mediated signaling | R-HSA-8939211 | 6.586704e-02 | 1.181 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.749722e-02 | 1.171 | 1 | 1 |
| HSF1 activation | R-HSA-3371511 | 7.109992e-02 | 1.148 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.256652e-02 | 1.139 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.261456e-02 | 1.139 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.261456e-02 | 1.139 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.261456e-02 | 1.139 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.287488e-02 | 1.137 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.336568e-02 | 1.135 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.385246e-02 | 1.132 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.428390e-02 | 1.129 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.861053e-02 | 1.105 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.861053e-02 | 1.105 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.895051e-02 | 1.103 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.928587e-02 | 1.101 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.526091e-02 | 1.021 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.526091e-02 | 1.021 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.526091e-02 | 1.021 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.526091e-02 | 1.021 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.526091e-02 | 1.021 | 0 | 0 |
| Signaling by FGFR2 amplification mutants | R-HSA-2023837 | 9.034059e-02 | 1.044 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 9.034059e-02 | 1.044 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 8.043854e-02 | 1.095 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.043854e-02 | 1.095 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.043854e-02 | 1.095 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 9.975577e-02 | 1.001 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.335535e-02 | 1.030 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.603690e-02 | 1.018 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.603690e-02 | 1.018 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.603690e-02 | 1.018 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.404944e-02 | 1.075 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.404944e-02 | 1.075 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.708249e-02 | 1.013 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.577112e-02 | 1.019 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.577112e-02 | 1.019 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.668990e-02 | 1.062 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 9.335535e-02 | 1.030 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 8.043854e-02 | 1.095 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.194111e-02 | 1.086 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.133046e-02 | 1.090 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.464516e-02 | 1.072 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.043854e-02 | 1.095 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 9.975577e-02 | 1.001 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.389271e-02 | 1.076 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.028546e-02 | 1.095 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.708249e-02 | 1.013 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 9.034059e-02 | 1.044 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.806143e-02 | 1.009 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 9.034059e-02 | 1.044 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.745823e-02 | 1.011 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.006727e-01 | 0.997 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.041155e-01 | 0.982 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.041155e-01 | 0.982 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.041155e-01 | 0.982 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.055894e-01 | 0.976 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.067030e-01 | 0.972 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.089061e-01 | 0.963 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.089061e-01 | 0.963 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 1.090192e-01 | 0.962 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.097416e-01 | 0.960 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.108552e-01 | 0.955 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.135052e-01 | 0.945 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.169357e-01 | 0.932 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.173328e-01 | 0.931 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.186057e-01 | 0.926 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.220855e-01 | 0.913 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.220855e-01 | 0.913 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.220855e-01 | 0.913 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.220855e-01 | 0.913 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 1.560393e-01 | 0.807 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.560393e-01 | 0.807 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.560393e-01 | 0.807 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.560393e-01 | 0.807 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.207231e-01 | 0.918 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.207231e-01 | 0.918 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.207231e-01 | 0.918 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.431386e-01 | 0.844 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.255299e-01 | 0.901 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.431457e-01 | 0.844 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.431457e-01 | 0.844 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.373543e-01 | 0.862 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.296979e-01 | 0.887 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.296979e-01 | 0.887 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.561895e-01 | 0.806 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.233363e-01 | 0.909 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.233363e-01 | 0.909 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.233363e-01 | 0.909 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.442809e-01 | 0.841 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.315434e-01 | 0.881 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.597844e-01 | 0.796 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.349308e-01 | 0.870 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.327747e-01 | 0.877 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 1.444806e-01 | 0.840 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.561895e-01 | 0.806 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.255299e-01 | 0.901 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.233363e-01 | 0.909 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.220855e-01 | 0.913 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 1.228050e-01 | 0.911 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.552402e-01 | 0.809 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.431457e-01 | 0.844 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.281024e-01 | 0.892 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.281024e-01 | 0.892 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.207231e-01 | 0.918 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.316609e-01 | 0.881 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.560393e-01 | 0.807 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.362833e-01 | 0.866 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.220855e-01 | 0.913 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.560393e-01 | 0.807 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.207231e-01 | 0.918 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.431386e-01 | 0.844 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.530319e-01 | 0.815 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.207231e-01 | 0.918 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.566593e-01 | 0.805 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.273737e-01 | 0.895 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.215606e-01 | 0.915 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.430519e-01 | 0.845 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.215606e-01 | 0.915 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.616655e-01 | 0.791 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.616655e-01 | 0.791 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.616655e-01 | 0.791 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.616655e-01 | 0.791 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.635615e-01 | 0.786 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.637939e-01 | 0.786 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.650436e-01 | 0.782 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.667966e-01 | 0.778 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.667966e-01 | 0.778 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.667966e-01 | 0.778 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.667966e-01 | 0.778 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.667966e-01 | 0.778 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.667966e-01 | 0.778 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.668491e-01 | 0.778 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.668491e-01 | 0.778 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.698127e-01 | 0.770 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.698127e-01 | 0.770 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.814523e-01 | 0.741 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.814523e-01 | 0.741 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.814523e-01 | 0.741 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.594371e-01 | 0.586 | 0 | 0 |
| Signaling by FGFR2 fusions | R-HSA-8853333 | 2.594371e-01 | 0.586 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.594371e-01 | 0.586 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.594371e-01 | 0.586 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.594371e-01 | 0.586 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.594371e-01 | 0.586 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 2.594371e-01 | 0.586 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.914937e-01 | 0.718 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.914937e-01 | 0.718 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.278552e-01 | 0.642 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.914924e-01 | 0.718 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.914924e-01 | 0.718 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.914924e-01 | 0.718 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.170269e-01 | 0.663 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.170269e-01 | 0.663 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.170269e-01 | 0.663 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 2.432090e-01 | 0.614 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 2.432090e-01 | 0.614 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.432090e-01 | 0.614 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.217136e-01 | 0.654 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.823492e-01 | 0.739 | 1 | 1 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.823492e-01 | 0.739 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.379144e-01 | 0.624 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.379144e-01 | 0.624 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.379144e-01 | 0.624 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.153360e-01 | 0.667 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.958127e-01 | 0.708 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.958127e-01 | 0.708 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.787038e-01 | 0.748 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 2.563682e-01 | 0.591 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.563682e-01 | 0.591 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.971005e-01 | 0.705 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.566368e-01 | 0.591 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.566368e-01 | 0.591 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.262080e-01 | 0.645 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.257049e-01 | 0.646 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.497472e-01 | 0.602 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.096543e-01 | 0.678 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.018768e-01 | 0.695 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.909157e-01 | 0.719 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.958127e-01 | 0.708 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.561387e-01 | 0.592 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.429055e-01 | 0.615 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.163344e-01 | 0.665 | 1 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.163344e-01 | 0.665 | 1 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.191517e-01 | 0.659 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 2.010453e-01 | 0.697 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.958127e-01 | 0.708 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.429419e-01 | 0.614 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.172781e-01 | 0.663 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.170269e-01 | 0.663 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.914924e-01 | 0.718 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.022281e-01 | 0.694 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.848276e-01 | 0.733 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.914937e-01 | 0.718 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.563682e-01 | 0.591 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.801325e-01 | 0.744 | 1 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.848276e-01 | 0.733 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.851128e-01 | 0.733 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.851128e-01 | 0.733 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.333761e-01 | 0.632 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.217136e-01 | 0.654 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.170269e-01 | 0.663 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.170269e-01 | 0.663 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.862791e-01 | 0.730 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.811890e-01 | 0.742 | 1 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.458179e-01 | 0.609 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 2.594371e-01 | 0.586 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.848276e-01 | 0.733 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.907331e-01 | 0.720 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.998664e-01 | 0.699 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.586767e-01 | 0.587 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.234467e-01 | 0.651 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.801325e-01 | 0.744 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.238469e-01 | 0.650 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.198480e-01 | 0.658 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.417387e-01 | 0.617 | 1 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.048742e-01 | 0.689 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.429055e-01 | 0.615 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.016027e-01 | 0.696 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.566368e-01 | 0.591 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.278552e-01 | 0.642 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.096543e-01 | 0.678 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.531708e-01 | 0.597 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.458561e-01 | 0.609 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.814523e-01 | 0.741 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.814523e-01 | 0.741 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.594371e-01 | 0.586 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.278552e-01 | 0.642 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.432090e-01 | 0.614 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.010453e-01 | 0.697 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.311976e-01 | 0.636 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.332587e-01 | 0.632 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.827869e-01 | 0.738 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.582284e-01 | 0.588 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.998664e-01 | 0.699 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.793949e-01 | 0.746 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.209414e-01 | 0.656 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.096543e-01 | 0.678 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.594371e-01 | 0.586 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.914937e-01 | 0.718 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.170269e-01 | 0.663 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.474115e-01 | 0.607 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.278552e-01 | 0.642 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 2.563682e-01 | 0.591 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.474115e-01 | 0.607 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.477974e-01 | 0.606 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.823492e-01 | 0.739 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.809971e-01 | 0.742 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.010453e-01 | 0.697 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.198480e-01 | 0.658 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.595351e-01 | 0.586 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.639375e-01 | 0.578 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.639375e-01 | 0.578 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.639375e-01 | 0.578 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.645257e-01 | 0.578 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.645257e-01 | 0.578 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.645257e-01 | 0.578 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.646296e-01 | 0.577 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.646296e-01 | 0.577 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.646296e-01 | 0.577 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.646296e-01 | 0.577 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.646296e-01 | 0.577 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.682435e-01 | 0.571 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.682435e-01 | 0.571 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 3.299963e-01 | 0.481 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.299963e-01 | 0.481 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.299963e-01 | 0.481 | 0 | 0 |
| Defective ALG14 causes ALG14-CMS | R-HSA-5633231 | 3.299963e-01 | 0.481 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.938365e-01 | 0.405 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 3.938365e-01 | 0.405 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 3.938365e-01 | 0.405 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.938365e-01 | 0.405 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 3.938365e-01 | 0.405 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.938365e-01 | 0.405 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 3.938365e-01 | 0.405 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.938365e-01 | 0.405 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.938365e-01 | 0.405 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.014086e-01 | 0.521 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.014086e-01 | 0.521 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.014086e-01 | 0.521 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.378577e-01 | 0.471 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.378577e-01 | 0.471 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.515973e-01 | 0.345 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 4.515973e-01 | 0.345 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.515973e-01 | 0.345 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.515973e-01 | 0.345 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.968055e-01 | 0.528 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.968055e-01 | 0.528 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.968055e-01 | 0.528 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.968055e-01 | 0.528 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.737061e-01 | 0.427 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.737061e-01 | 0.427 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.238954e-01 | 0.490 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.086821e-01 | 0.510 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.509852e-01 | 0.455 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.087377e-01 | 0.389 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.087377e-01 | 0.389 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.038571e-01 | 0.298 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.038571e-01 | 0.298 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.038571e-01 | 0.298 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.038571e-01 | 0.298 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.779460e-01 | 0.423 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.779460e-01 | 0.423 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.779460e-01 | 0.423 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.134690e-01 | 0.504 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.427826e-01 | 0.354 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.427826e-01 | 0.354 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 2.705621e-01 | 0.568 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.705621e-01 | 0.568 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.149808e-01 | 0.502 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.046622e-01 | 0.393 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.524152e-01 | 0.453 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.323490e-01 | 0.478 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.990109e-01 | 0.524 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.134871e-01 | 0.504 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.310315e-01 | 0.365 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.757111e-01 | 0.323 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.757111e-01 | 0.323 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.948087e-01 | 0.530 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.205000e-01 | 0.376 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.569638e-01 | 0.340 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.110868e-01 | 0.386 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.725201e-01 | 0.429 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.425207e-01 | 0.354 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.823815e-01 | 0.317 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.823815e-01 | 0.317 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.823815e-01 | 0.317 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.823815e-01 | 0.317 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.642826e-01 | 0.333 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.642826e-01 | 0.333 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.642826e-01 | 0.333 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.498127e-01 | 0.347 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.498127e-01 | 0.347 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.569769e-01 | 0.447 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.226392e-01 | 0.374 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.857346e-01 | 0.314 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.072179e-01 | 0.295 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.072179e-01 | 0.295 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.072179e-01 | 0.295 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.072179e-01 | 0.295 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.378616e-01 | 0.269 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.378616e-01 | 0.269 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.722245e-01 | 0.326 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.068306e-01 | 0.295 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.068306e-01 | 0.295 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.275297e-01 | 0.278 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.248818e-01 | 0.280 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.298783e-01 | 0.276 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.835403e-01 | 0.316 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.625329e-01 | 0.441 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.580470e-01 | 0.339 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.712734e-01 | 0.567 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.375873e-01 | 0.359 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.025532e-01 | 0.395 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.316754e-01 | 0.479 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.946286e-01 | 0.404 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.946286e-01 | 0.404 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.012575e-01 | 0.521 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.316754e-01 | 0.479 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.316754e-01 | 0.479 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.913335e-01 | 0.309 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 5.378616e-01 | 0.269 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.134871e-01 | 0.504 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.751507e-01 | 0.560 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.737061e-01 | 0.427 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.715900e-01 | 0.566 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.323490e-01 | 0.478 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.323490e-01 | 0.478 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.378616e-01 | 0.269 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.737061e-01 | 0.427 | 1 | 1 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.534783e-01 | 0.452 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.576394e-01 | 0.447 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.375875e-01 | 0.270 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.087377e-01 | 0.389 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.719890e-01 | 0.429 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.512011e-01 | 0.454 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.314171e-01 | 0.275 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.737061e-01 | 0.427 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.046622e-01 | 0.393 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.086821e-01 | 0.510 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.968055e-01 | 0.528 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.498127e-01 | 0.347 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.238954e-01 | 0.490 | 1 | 1 |
| Unwinding of DNA | R-HSA-176974 | 3.378577e-01 | 0.471 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.515973e-01 | 0.345 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.757111e-01 | 0.323 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.205000e-01 | 0.376 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.524152e-01 | 0.453 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.747011e-01 | 0.426 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.322570e-01 | 0.364 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.942035e-01 | 0.531 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.857346e-01 | 0.314 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.460911e-01 | 0.351 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.942035e-01 | 0.531 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.074267e-01 | 0.295 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.534783e-01 | 0.452 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.280997e-01 | 0.484 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.238954e-01 | 0.490 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.238954e-01 | 0.490 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.509852e-01 | 0.455 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.087377e-01 | 0.389 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.038571e-01 | 0.298 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.427826e-01 | 0.354 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.849669e-01 | 0.415 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.074267e-01 | 0.295 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.686440e-01 | 0.329 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.126926e-01 | 0.290 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.323490e-01 | 0.478 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.323490e-01 | 0.478 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.287571e-01 | 0.277 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.968055e-01 | 0.528 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.455987e-01 | 0.461 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.627999e-01 | 0.440 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.061402e-01 | 0.391 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.515973e-01 | 0.345 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.515973e-01 | 0.345 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.515973e-01 | 0.345 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 2.968055e-01 | 0.528 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 3.737061e-01 | 0.427 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.038571e-01 | 0.298 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.046622e-01 | 0.393 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.673798e-01 | 0.435 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.682282e-01 | 0.434 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.529844e-01 | 0.344 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.040734e-01 | 0.517 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.012077e-01 | 0.521 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.271392e-01 | 0.485 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.642826e-01 | 0.333 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.725770e-01 | 0.326 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.861973e-01 | 0.413 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.192656e-01 | 0.285 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.942035e-01 | 0.531 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.864813e-01 | 0.543 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.086821e-01 | 0.510 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.779460e-01 | 0.423 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.524152e-01 | 0.453 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.205000e-01 | 0.376 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.665941e-01 | 0.331 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.369784e-01 | 0.360 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.134871e-01 | 0.504 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.025532e-01 | 0.395 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.864813e-01 | 0.543 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.747180e-01 | 0.324 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.046622e-01 | 0.393 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.982772e-01 | 0.400 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.759142e-01 | 0.425 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.815343e-01 | 0.550 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.490462e-01 | 0.457 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.299963e-01 | 0.481 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.299963e-01 | 0.481 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.938365e-01 | 0.405 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.938365e-01 | 0.405 | 0 | 0 |
| Adenosine P1 receptors | R-HSA-417973 | 3.938365e-01 | 0.405 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.378577e-01 | 0.471 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.515973e-01 | 0.345 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 4.087377e-01 | 0.389 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.087377e-01 | 0.389 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.087377e-01 | 0.389 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.038571e-01 | 0.298 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.038571e-01 | 0.298 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.807348e-01 | 0.552 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.427826e-01 | 0.354 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 3.915621e-01 | 0.407 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.074267e-01 | 0.295 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.642826e-01 | 0.333 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.173341e-01 | 0.380 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.068306e-01 | 0.295 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.064988e-01 | 0.295 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.366787e-01 | 0.270 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.961817e-01 | 0.528 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.715848e-01 | 0.430 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.715848e-01 | 0.430 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.201044e-01 | 0.377 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.201044e-01 | 0.377 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.480226e-01 | 0.458 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.770815e-01 | 0.557 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.725201e-01 | 0.429 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.310315e-01 | 0.365 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.747180e-01 | 0.324 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.057208e-01 | 0.296 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.322570e-01 | 0.364 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.038571e-01 | 0.298 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.425207e-01 | 0.354 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.534582e-01 | 0.343 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.569638e-01 | 0.340 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.068306e-01 | 0.295 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.874442e-01 | 0.412 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.759142e-01 | 0.425 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.086821e-01 | 0.510 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.074267e-01 | 0.295 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.378616e-01 | 0.269 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.310719e-01 | 0.480 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.205000e-01 | 0.376 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.055206e-01 | 0.296 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.299963e-01 | 0.481 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.698581e-01 | 0.569 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.737061e-01 | 0.427 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.427826e-01 | 0.354 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 4.425207e-01 | 0.354 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.823815e-01 | 0.317 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.878385e-01 | 0.312 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.882232e-01 | 0.311 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.072179e-01 | 0.295 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.823815e-01 | 0.317 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.737061e-01 | 0.427 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.968055e-01 | 0.528 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.524152e-01 | 0.453 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.991993e-01 | 0.399 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.699045e-01 | 0.569 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.248818e-01 | 0.280 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.968055e-01 | 0.528 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.427826e-01 | 0.354 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.074267e-01 | 0.295 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.642826e-01 | 0.333 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.072179e-01 | 0.295 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.072179e-01 | 0.295 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.588707e-01 | 0.338 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.759142e-01 | 0.425 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 3.067817e-01 | 0.513 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.248818e-01 | 0.280 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.014086e-01 | 0.521 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.014086e-01 | 0.521 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.378577e-01 | 0.471 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.874126e-01 | 0.412 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.698581e-01 | 0.569 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.625329e-01 | 0.441 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.394146e-01 | 0.268 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.429595e-01 | 0.265 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.477960e-01 | 0.261 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.477960e-01 | 0.261 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.477960e-01 | 0.261 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.477960e-01 | 0.261 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.477960e-01 | 0.261 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.477960e-01 | 0.261 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.485677e-01 | 0.261 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.498588e-01 | 0.260 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.511397e-01 | 0.259 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.511397e-01 | 0.259 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.511397e-01 | 0.259 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.511397e-01 | 0.259 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.511397e-01 | 0.259 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.511397e-01 | 0.259 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.511397e-01 | 0.259 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.511397e-01 | 0.259 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.511397e-01 | 0.259 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.511397e-01 | 0.259 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.511397e-01 | 0.259 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.511397e-01 | 0.259 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.511397e-01 | 0.259 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.511397e-01 | 0.259 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.511397e-01 | 0.259 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.511397e-01 | 0.259 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.537453e-01 | 0.257 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.549330e-01 | 0.256 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.549330e-01 | 0.256 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.549330e-01 | 0.256 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.549330e-01 | 0.256 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.575049e-01 | 0.254 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.624707e-01 | 0.250 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.646931e-01 | 0.248 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.665389e-01 | 0.247 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.665389e-01 | 0.247 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.669719e-01 | 0.246 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.669719e-01 | 0.246 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.669719e-01 | 0.246 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.669719e-01 | 0.246 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.675982e-01 | 0.246 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.715931e-01 | 0.243 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.745612e-01 | 0.241 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.777285e-01 | 0.238 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.777285e-01 | 0.238 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.777285e-01 | 0.238 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.777285e-01 | 0.238 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.777285e-01 | 0.238 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.777285e-01 | 0.238 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.853450e-01 | 0.233 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.869097e-01 | 0.231 | 1 | 1 |
| Signal amplification | R-HSA-392518 | 5.869097e-01 | 0.231 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.869097e-01 | 0.231 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.869097e-01 | 0.231 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.872606e-01 | 0.231 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.938632e-01 | 0.226 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.939187e-01 | 0.226 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.939187e-01 | 0.226 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 5.939187e-01 | 0.226 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.939187e-01 | 0.226 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.939187e-01 | 0.226 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.939187e-01 | 0.226 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.939187e-01 | 0.226 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.939187e-01 | 0.226 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.939187e-01 | 0.226 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.939187e-01 | 0.226 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.939187e-01 | 0.226 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.939187e-01 | 0.226 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 5.939187e-01 | 0.226 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 5.947337e-01 | 0.226 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.947337e-01 | 0.226 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.947337e-01 | 0.226 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.947337e-01 | 0.226 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 5.947337e-01 | 0.226 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 5.947337e-01 | 0.226 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.947337e-01 | 0.226 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.947337e-01 | 0.226 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.947337e-01 | 0.226 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.947337e-01 | 0.226 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.947337e-01 | 0.226 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.947337e-01 | 0.226 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.947337e-01 | 0.226 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.963127e-01 | 0.225 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.997747e-01 | 0.222 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.997747e-01 | 0.222 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.014403e-01 | 0.221 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.057080e-01 | 0.218 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 6.057080e-01 | 0.218 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.079256e-01 | 0.216 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.115013e-01 | 0.214 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.117521e-01 | 0.213 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.127387e-01 | 0.213 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.210503e-01 | 0.207 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.210503e-01 | 0.207 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.210503e-01 | 0.207 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.210503e-01 | 0.207 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.210503e-01 | 0.207 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.211396e-01 | 0.207 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.211396e-01 | 0.207 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.211396e-01 | 0.207 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.239749e-01 | 0.205 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.279781e-01 | 0.202 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.279781e-01 | 0.202 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.326230e-01 | 0.199 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.326230e-01 | 0.199 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.326230e-01 | 0.199 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.326230e-01 | 0.199 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.326230e-01 | 0.199 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.326230e-01 | 0.199 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.326230e-01 | 0.199 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.326230e-01 | 0.199 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.326230e-01 | 0.199 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.326230e-01 | 0.199 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.326230e-01 | 0.199 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 6.326230e-01 | 0.199 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.326230e-01 | 0.199 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.326230e-01 | 0.199 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.326230e-01 | 0.199 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.326230e-01 | 0.199 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.326230e-01 | 0.199 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.360114e-01 | 0.197 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.388029e-01 | 0.195 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.393600e-01 | 0.194 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.415408e-01 | 0.193 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.415408e-01 | 0.193 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.437868e-01 | 0.191 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.461958e-01 | 0.190 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.461958e-01 | 0.190 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.461958e-01 | 0.190 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.461958e-01 | 0.190 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.531177e-01 | 0.185 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.577598e-01 | 0.182 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.583061e-01 | 0.182 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.588596e-01 | 0.181 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.588596e-01 | 0.181 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.608213e-01 | 0.180 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.676403e-01 | 0.175 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.676403e-01 | 0.175 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.676403e-01 | 0.175 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.676403e-01 | 0.175 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.676403e-01 | 0.175 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.676403e-01 | 0.175 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.676403e-01 | 0.175 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.676403e-01 | 0.175 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.676403e-01 | 0.175 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.676403e-01 | 0.175 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.676403e-01 | 0.175 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.676403e-01 | 0.175 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.676403e-01 | 0.175 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.699197e-01 | 0.174 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.699197e-01 | 0.174 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.699197e-01 | 0.174 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.699197e-01 | 0.174 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.699197e-01 | 0.174 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.699197e-01 | 0.174 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.699197e-01 | 0.174 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.699197e-01 | 0.174 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.741144e-01 | 0.171 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.744185e-01 | 0.171 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.745058e-01 | 0.171 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.750045e-01 | 0.171 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.758891e-01 | 0.170 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.801378e-01 | 0.167 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.801378e-01 | 0.167 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.801378e-01 | 0.167 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.828334e-01 | 0.166 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.863446e-01 | 0.163 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.897793e-01 | 0.161 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.914881e-01 | 0.160 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.914881e-01 | 0.160 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.923376e-01 | 0.160 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.923376e-01 | 0.160 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.923376e-01 | 0.160 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.923376e-01 | 0.160 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.923376e-01 | 0.160 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.978583e-01 | 0.156 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.982427e-01 | 0.156 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.989970e-01 | 0.156 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.993218e-01 | 0.155 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.993218e-01 | 0.155 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 6.993218e-01 | 0.155 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.993218e-01 | 0.155 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.993218e-01 | 0.155 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.993218e-01 | 0.155 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.993218e-01 | 0.155 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.993218e-01 | 0.155 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.993218e-01 | 0.155 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.993218e-01 | 0.155 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.993218e-01 | 0.155 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.993218e-01 | 0.155 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.993218e-01 | 0.155 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.993218e-01 | 0.155 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.993218e-01 | 0.155 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.993218e-01 | 0.155 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.993218e-01 | 0.155 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.007919e-01 | 0.154 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.069459e-01 | 0.151 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.134828e-01 | 0.147 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.134828e-01 | 0.147 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.134828e-01 | 0.147 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.155584e-01 | 0.145 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.155584e-01 | 0.145 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.155584e-01 | 0.145 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.162906e-01 | 0.145 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.218327e-01 | 0.142 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.218327e-01 | 0.142 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.218327e-01 | 0.142 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.235383e-01 | 0.141 | 1 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.235383e-01 | 0.141 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.238807e-01 | 0.140 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.279850e-01 | 0.138 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.279850e-01 | 0.138 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.279850e-01 | 0.138 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.279850e-01 | 0.138 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.279850e-01 | 0.138 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.279850e-01 | 0.138 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.279850e-01 | 0.138 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.279850e-01 | 0.138 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.279850e-01 | 0.138 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.279850e-01 | 0.138 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.279850e-01 | 0.138 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.279850e-01 | 0.138 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.279850e-01 | 0.138 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.279850e-01 | 0.138 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.294541e-01 | 0.137 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.298116e-01 | 0.137 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.329661e-01 | 0.135 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.333943e-01 | 0.135 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.333943e-01 | 0.135 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.361510e-01 | 0.133 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.374654e-01 | 0.132 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.421700e-01 | 0.129 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.478627e-01 | 0.126 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.499057e-01 | 0.125 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.521151e-01 | 0.124 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.521151e-01 | 0.124 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.521151e-01 | 0.124 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.521151e-01 | 0.124 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.539173e-01 | 0.123 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.539173e-01 | 0.123 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.539173e-01 | 0.123 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.539173e-01 | 0.123 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.539173e-01 | 0.123 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.539173e-01 | 0.123 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.539173e-01 | 0.123 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.539173e-01 | 0.123 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.539173e-01 | 0.123 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.539173e-01 | 0.123 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.539173e-01 | 0.123 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.544404e-01 | 0.122 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.628791e-01 | 0.118 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.628791e-01 | 0.118 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.628791e-01 | 0.118 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.628791e-01 | 0.118 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.631033e-01 | 0.117 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.662689e-01 | 0.116 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.666797e-01 | 0.115 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.670045e-01 | 0.115 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.672994e-01 | 0.115 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.696912e-01 | 0.114 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.696912e-01 | 0.114 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.696912e-01 | 0.114 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.696912e-01 | 0.114 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.696912e-01 | 0.114 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.696912e-01 | 0.114 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.708168e-01 | 0.113 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.757520e-01 | 0.110 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.757520e-01 | 0.110 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.757520e-01 | 0.110 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.757520e-01 | 0.110 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.760375e-01 | 0.110 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.760375e-01 | 0.110 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.770145e-01 | 0.110 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.771610e-01 | 0.109 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.771610e-01 | 0.109 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.771610e-01 | 0.109 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.771610e-01 | 0.109 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.773787e-01 | 0.109 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 7.773787e-01 | 0.109 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 7.773787e-01 | 0.109 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.773787e-01 | 0.109 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.773787e-01 | 0.109 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.773787e-01 | 0.109 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.773787e-01 | 0.109 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.776598e-01 | 0.109 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.776598e-01 | 0.109 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.826531e-01 | 0.106 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.861705e-01 | 0.104 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.861705e-01 | 0.104 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.861705e-01 | 0.104 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.861705e-01 | 0.104 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.861705e-01 | 0.104 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.861705e-01 | 0.104 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.878614e-01 | 0.104 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.878614e-01 | 0.104 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.878614e-01 | 0.104 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.878614e-01 | 0.104 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.878614e-01 | 0.104 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.880531e-01 | 0.103 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.907275e-01 | 0.102 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.907275e-01 | 0.102 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.912294e-01 | 0.102 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.948488e-01 | 0.100 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.954870e-01 | 0.099 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.986046e-01 | 0.098 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.986046e-01 | 0.098 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.986046e-01 | 0.098 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.986046e-01 | 0.098 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.986046e-01 | 0.098 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.986046e-01 | 0.098 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.986046e-01 | 0.098 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.986046e-01 | 0.098 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.986046e-01 | 0.098 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.986046e-01 | 0.098 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.986046e-01 | 0.098 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.986046e-01 | 0.098 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 7.986046e-01 | 0.098 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.986046e-01 | 0.098 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.986046e-01 | 0.098 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.986046e-01 | 0.098 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.986046e-01 | 0.098 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.993337e-01 | 0.097 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.009000e-01 | 0.096 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.009000e-01 | 0.096 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.016026e-01 | 0.096 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.016026e-01 | 0.096 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.016026e-01 | 0.096 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.016026e-01 | 0.096 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.035995e-01 | 0.095 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.039495e-01 | 0.095 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.073559e-01 | 0.093 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.081521e-01 | 0.093 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.102201e-01 | 0.091 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.105063e-01 | 0.091 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.113044e-01 | 0.091 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.124392e-01 | 0.090 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.157989e-01 | 0.088 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.157989e-01 | 0.088 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.160371e-01 | 0.088 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.160371e-01 | 0.088 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.178079e-01 | 0.087 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.178079e-01 | 0.087 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.178079e-01 | 0.087 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.178079e-01 | 0.087 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.178079e-01 | 0.087 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.178079e-01 | 0.087 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.178079e-01 | 0.087 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.178079e-01 | 0.087 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.178079e-01 | 0.087 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.178079e-01 | 0.087 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.178079e-01 | 0.087 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.178079e-01 | 0.087 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.178079e-01 | 0.087 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.189730e-01 | 0.087 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.207861e-01 | 0.086 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.273485e-01 | 0.082 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.295240e-01 | 0.081 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.295240e-01 | 0.081 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.295240e-01 | 0.081 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.295240e-01 | 0.081 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.295240e-01 | 0.081 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.332719e-01 | 0.079 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.351811e-01 | 0.078 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.351811e-01 | 0.078 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.351811e-01 | 0.078 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.351811e-01 | 0.078 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.351811e-01 | 0.078 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.351811e-01 | 0.078 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.351811e-01 | 0.078 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.351811e-01 | 0.078 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.351811e-01 | 0.078 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.351811e-01 | 0.078 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.351811e-01 | 0.078 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.351811e-01 | 0.078 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.351811e-01 | 0.078 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.351811e-01 | 0.078 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.351811e-01 | 0.078 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.380518e-01 | 0.077 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.382720e-01 | 0.077 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.382720e-01 | 0.077 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.383625e-01 | 0.077 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.421126e-01 | 0.075 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.421126e-01 | 0.075 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.421126e-01 | 0.075 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.421126e-01 | 0.075 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.421126e-01 | 0.075 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.440888e-01 | 0.074 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.441125e-01 | 0.074 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.485931e-01 | 0.071 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.485931e-01 | 0.071 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.485931e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.498592e-01 | 0.071 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.498592e-01 | 0.071 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.498592e-01 | 0.071 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.508986e-01 | 0.070 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.508986e-01 | 0.070 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.508986e-01 | 0.070 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.508986e-01 | 0.070 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.508986e-01 | 0.070 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.508986e-01 | 0.070 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.508986e-01 | 0.070 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.508986e-01 | 0.070 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.508986e-01 | 0.070 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.508986e-01 | 0.070 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.508986e-01 | 0.070 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.508986e-01 | 0.070 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.508986e-01 | 0.070 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.538517e-01 | 0.069 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.538517e-01 | 0.069 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.538517e-01 | 0.069 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.538517e-01 | 0.069 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.538732e-01 | 0.069 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.583360e-01 | 0.066 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.583360e-01 | 0.066 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.591205e-01 | 0.066 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.591205e-01 | 0.066 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.647887e-01 | 0.063 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.647887e-01 | 0.063 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.647887e-01 | 0.063 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.647887e-01 | 0.063 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.648971e-01 | 0.063 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.648971e-01 | 0.063 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.651181e-01 | 0.063 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.651181e-01 | 0.063 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.651181e-01 | 0.063 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.651181e-01 | 0.063 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.651181e-01 | 0.063 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.661659e-01 | 0.062 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.675249e-01 | 0.062 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.675249e-01 | 0.062 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.675249e-01 | 0.062 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.746283e-01 | 0.058 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.749698e-01 | 0.058 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.761839e-01 | 0.057 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.761839e-01 | 0.057 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.761839e-01 | 0.057 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.761839e-01 | 0.057 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.761839e-01 | 0.057 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.762093e-01 | 0.057 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.762093e-01 | 0.057 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.767060e-01 | 0.057 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.774300e-01 | 0.057 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.779823e-01 | 0.057 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.779823e-01 | 0.057 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 8.779823e-01 | 0.057 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.779823e-01 | 0.057 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.779823e-01 | 0.057 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.779823e-01 | 0.057 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.812071e-01 | 0.055 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.820610e-01 | 0.055 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.829797e-01 | 0.054 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.833715e-01 | 0.054 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.843367e-01 | 0.053 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.844397e-01 | 0.053 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.844397e-01 | 0.053 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.894307e-01 | 0.051 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.896202e-01 | 0.051 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.896202e-01 | 0.051 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.896202e-01 | 0.051 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.896202e-01 | 0.051 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.896202e-01 | 0.051 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.896202e-01 | 0.051 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.920070e-01 | 0.050 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.932413e-01 | 0.049 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.944766e-01 | 0.048 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.955733e-01 | 0.048 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.957827e-01 | 0.048 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.972165e-01 | 0.047 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.992179e-01 | 0.046 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.992179e-01 | 0.046 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.001488e-01 | 0.046 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.001488e-01 | 0.046 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.001488e-01 | 0.046 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.001488e-01 | 0.046 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.001488e-01 | 0.046 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.001488e-01 | 0.046 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.001488e-01 | 0.046 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.005460e-01 | 0.045 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.014160e-01 | 0.045 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.014160e-01 | 0.045 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.014183e-01 | 0.045 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.014183e-01 | 0.045 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.017902e-01 | 0.045 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.037220e-01 | 0.044 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.059917e-01 | 0.043 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.059917e-01 | 0.043 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.069766e-01 | 0.042 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.069766e-01 | 0.042 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.090033e-01 | 0.041 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.090033e-01 | 0.041 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.090033e-01 | 0.041 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.096736e-01 | 0.041 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.096736e-01 | 0.041 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.096736e-01 | 0.041 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.096736e-01 | 0.041 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.096736e-01 | 0.041 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.096736e-01 | 0.041 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.096736e-01 | 0.041 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.118600e-01 | 0.040 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.122591e-01 | 0.040 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.122591e-01 | 0.040 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.123507e-01 | 0.040 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.137318e-01 | 0.039 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.160407e-01 | 0.038 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.160407e-01 | 0.038 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.160407e-01 | 0.038 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.177650e-01 | 0.037 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.182904e-01 | 0.037 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.182904e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.182904e-01 | 0.037 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.182904e-01 | 0.037 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.182904e-01 | 0.037 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.182904e-01 | 0.037 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.182904e-01 | 0.037 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.182904e-01 | 0.037 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.182904e-01 | 0.037 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.182904e-01 | 0.037 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.183160e-01 | 0.037 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.183160e-01 | 0.037 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.183160e-01 | 0.037 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.183160e-01 | 0.037 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.190714e-01 | 0.037 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.190714e-01 | 0.037 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.201802e-01 | 0.036 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.225641e-01 | 0.035 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.243411e-01 | 0.034 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.260857e-01 | 0.033 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.260857e-01 | 0.033 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.260857e-01 | 0.033 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.260857e-01 | 0.033 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.260857e-01 | 0.033 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.260857e-01 | 0.033 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.260857e-01 | 0.033 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.278151e-01 | 0.033 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.278151e-01 | 0.033 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.286076e-01 | 0.032 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.286076e-01 | 0.032 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.286076e-01 | 0.032 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.326319e-01 | 0.030 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.328932e-01 | 0.030 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.331376e-01 | 0.030 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.331376e-01 | 0.030 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.331376e-01 | 0.030 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.331376e-01 | 0.030 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.331376e-01 | 0.030 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.340540e-01 | 0.030 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.342032e-01 | 0.030 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.342032e-01 | 0.030 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.342032e-01 | 0.030 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.393815e-01 | 0.027 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.395172e-01 | 0.027 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.395172e-01 | 0.027 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.395172e-01 | 0.027 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.395172e-01 | 0.027 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.395172e-01 | 0.027 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.395172e-01 | 0.027 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.395172e-01 | 0.027 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.395172e-01 | 0.027 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.395172e-01 | 0.027 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.395172e-01 | 0.027 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.395172e-01 | 0.027 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.395172e-01 | 0.027 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.395172e-01 | 0.027 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.407612e-01 | 0.027 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.410410e-01 | 0.026 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.415680e-01 | 0.026 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.429384e-01 | 0.026 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.429384e-01 | 0.026 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.441710e-01 | 0.025 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.441710e-01 | 0.025 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.452884e-01 | 0.024 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.452884e-01 | 0.024 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.452884e-01 | 0.024 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.452884e-01 | 0.024 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.469516e-01 | 0.024 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.482026e-01 | 0.023 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.485988e-01 | 0.023 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.485988e-01 | 0.023 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.485988e-01 | 0.023 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.490816e-01 | 0.023 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.505092e-01 | 0.022 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.505092e-01 | 0.022 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.526903e-01 | 0.021 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.527057e-01 | 0.021 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.552321e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.552321e-01 | 0.020 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.552321e-01 | 0.020 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.552321e-01 | 0.020 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.552321e-01 | 0.020 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.552844e-01 | 0.020 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.552844e-01 | 0.020 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.564694e-01 | 0.019 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.564694e-01 | 0.019 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.564694e-01 | 0.019 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.573202e-01 | 0.019 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.575063e-01 | 0.019 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.576172e-01 | 0.019 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.599583e-01 | 0.018 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.599583e-01 | 0.018 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.633695e-01 | 0.016 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.633695e-01 | 0.016 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.633695e-01 | 0.016 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.636166e-01 | 0.016 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.647810e-01 | 0.016 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.651503e-01 | 0.015 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.652415e-01 | 0.015 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.653531e-01 | 0.015 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.659744e-01 | 0.015 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.660063e-01 | 0.015 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.661482e-01 | 0.015 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.661482e-01 | 0.015 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.661482e-01 | 0.015 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.661482e-01 | 0.015 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.668657e-01 | 0.015 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.668657e-01 | 0.015 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.668657e-01 | 0.015 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.668657e-01 | 0.015 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.668657e-01 | 0.015 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.673226e-01 | 0.014 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.684732e-01 | 0.014 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.688871e-01 | 0.014 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.688871e-01 | 0.014 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.688871e-01 | 0.014 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.688871e-01 | 0.014 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.700285e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.700285e-01 | 0.013 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.700285e-01 | 0.013 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.714118e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.714118e-01 | 0.013 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.720118e-01 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.723743e-01 | 0.012 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.726852e-01 | 0.012 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.728895e-01 | 0.012 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.728895e-01 | 0.012 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.728895e-01 | 0.012 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.737382e-01 | 0.012 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.754776e-01 | 0.011 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.754776e-01 | 0.011 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.754776e-01 | 0.011 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.756517e-01 | 0.011 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.759788e-01 | 0.011 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.761074e-01 | 0.011 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.774883e-01 | 0.010 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.778187e-01 | 0.010 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.778544e-01 | 0.010 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.778544e-01 | 0.010 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.780390e-01 | 0.010 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.788577e-01 | 0.009 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.796709e-01 | 0.009 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.799365e-01 | 0.009 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.799365e-01 | 0.009 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.801494e-01 | 0.009 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.813426e-01 | 0.008 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.814843e-01 | 0.008 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.818522e-01 | 0.008 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.818522e-01 | 0.008 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.818522e-01 | 0.008 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.828805e-01 | 0.007 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.835850e-01 | 0.007 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.835850e-01 | 0.007 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.835850e-01 | 0.007 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.835850e-01 | 0.007 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.835850e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.835850e-01 | 0.007 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.835850e-01 | 0.007 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.842064e-01 | 0.007 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.842949e-01 | 0.007 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.843589e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.851525e-01 | 0.006 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.851525e-01 | 0.006 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.851525e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.852548e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.853938e-01 | 0.006 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.857821e-01 | 0.006 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.862259e-01 | 0.006 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.863156e-01 | 0.006 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.864699e-01 | 0.006 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.864953e-01 | 0.006 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.865704e-01 | 0.006 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.865704e-01 | 0.006 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.865704e-01 | 0.006 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.865704e-01 | 0.006 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.867909e-01 | 0.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.878081e-01 | 0.005 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.878530e-01 | 0.005 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.878530e-01 | 0.005 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.878530e-01 | 0.005 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.878530e-01 | 0.005 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.888784e-01 | 0.005 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.888988e-01 | 0.005 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.890132e-01 | 0.005 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.890132e-01 | 0.005 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.890132e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.890132e-01 | 0.005 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.891353e-01 | 0.005 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.900626e-01 | 0.004 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.900626e-01 | 0.004 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.900626e-01 | 0.004 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.901544e-01 | 0.004 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.906772e-01 | 0.004 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.906772e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.909075e-01 | 0.004 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.910118e-01 | 0.004 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.910118e-01 | 0.004 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.910118e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.910118e-01 | 0.004 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.912948e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.914588e-01 | 0.004 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.914588e-01 | 0.004 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.916949e-01 | 0.004 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.918704e-01 | 0.004 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.918704e-01 | 0.004 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.918704e-01 | 0.004 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.921585e-01 | 0.003 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.921762e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.922505e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.924992e-01 | 0.003 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.926230e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.926470e-01 | 0.003 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.926470e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.926470e-01 | 0.003 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.928346e-01 | 0.003 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.928479e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.934007e-01 | 0.003 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.934007e-01 | 0.003 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.934386e-01 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.935954e-01 | 0.003 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.939849e-01 | 0.003 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.939926e-01 | 0.003 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.939926e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.944446e-01 | 0.002 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.945007e-01 | 0.002 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.945597e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.949666e-01 | 0.002 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.950067e-01 | 0.002 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.950795e-01 | 0.002 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.950795e-01 | 0.002 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.951763e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.953937e-01 | 0.002 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.953937e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.953937e-01 | 0.002 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.955497e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.955766e-01 | 0.002 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.957852e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.957852e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.959750e-01 | 0.002 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.960901e-01 | 0.002 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.961216e-01 | 0.002 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.962119e-01 | 0.002 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.962625e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.962625e-01 | 0.002 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.962811e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.963238e-01 | 0.002 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.963597e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.966427e-01 | 0.001 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.966457e-01 | 0.001 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.967436e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.967738e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.967738e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.970223e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.973022e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.973069e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.973069e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.975235e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.977204e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.979019e-01 | 0.001 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.980078e-01 | 0.001 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.980078e-01 | 0.001 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.980412e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.981983e-01 | 0.001 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.982236e-01 | 0.001 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.982711e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.982786e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.982786e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.983607e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.983658e-01 | 0.001 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.983706e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.983706e-01 | 0.001 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.984044e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.984606e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.984969e-01 | 0.001 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.986673e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.987289e-01 | 0.001 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.987462e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.987891e-01 | 0.001 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.987947e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.988938e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.989100e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.989100e-01 | 0.000 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.989100e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.989100e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990143e-01 | 0.000 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.990143e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.991086e-01 | 0.000 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.991676e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992387e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.992709e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.993481e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.993644e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.993657e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.994446e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994608e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.994608e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994700e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.995178e-01 | 0.000 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.995593e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.995750e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.995986e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.996013e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.996149e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.996394e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.996479e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.996660e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.996739e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.997221e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.997221e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997249e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997466e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.997980e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998058e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998217e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.998249e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998388e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.998403e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998435e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.998444e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.998673e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998682e-01 | 0.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.998871e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.998883e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.998883e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.998883e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999025e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.999166e-01 | 0.000 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.999240e-01 | 0.000 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.999240e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999280e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999401e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999411e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999411e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999518e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999672e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999678e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.999701e-01 | 0.000 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.999701e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999742e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999762e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999785e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999821e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999821e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999824e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999872e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999880e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999885e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999894e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999894e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999895e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999903e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999929e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999932e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999940e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999945e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999948e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999957e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999959e-01 | 0.000 | 1 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999961e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999971e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999979e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999980e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999985e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999987e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999987e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999990e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999992e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999992e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999995e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |